腫瘍病理鑑別診断アトラス　縦隔腫瘍・胸膜腫瘍　第2版

出版社： 文光堂
著者：
発行日： 2022-04-15
分野： 臨床医学：基礎  >  臨床病理学
ISBN： 9784830622601
シリーズ： 腫瘍病理鑑別診断アトラス
電子書籍版： 2022-04-15 （第2版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

17,600 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

17,600 円(税込)

購入する

商品紹介

腫瘍病理鑑別診断アトラスシリーズ「縦隔腫瘍・胸膜腫瘍」，待望の第2版．2014年の初版発行から8年，2021年にはWHO分類第5版が刊行され，当該領域の臨床・病理を取り巻く環境は日々変化している．そうした状況を踏まえて，胸部腫瘍病理のエキスパートたちが精選した病理写真とともに，定義や概念，診断上の要点を解説した．縦隔腫瘍・胸膜腫瘍病理診断の標準化を図りつつ鑑別ポイントをも網羅し，さらに，臨床との連携では欠かせないX線所見のみかたや治療法も解説した．希少症例が多い縦隔・胸膜領域の病理診断において即戦力となる．

目次

  • ［縦隔腫瘍］
    第1部　検鏡前の確認事項
    　I．縦隔腫瘍－WHO分類 第5版（2021）のコンセプト
    　II．病理標本の扱い方：検体の取扱い　

    第2部　組織型と診断の実際
    　I．胸腺上皮性腫瘍
    　　1．胸腺腫
    　　（1）A型（異型A型を含む），B型，AB型，B1型，B2型，B3型胸腺腫
    　　（2）リンパ性間質を伴う小結節性胸腺腫，化生性胸腺腫，脂肪線維腺腫，
    　　　　　いわゆる顕微鏡的胸腺腫といわゆる硬化性胸腺腫
    　　2．胸腺癌
    　　（1）扁平上皮癌　
    　　（2）類基底癌　
    　　（3）リンパ上皮癌
    　　（4）NUT癌
    　　（5）明細胞癌　
    　　（6）低異型度乳頭状腺癌　
    　　（7）粘表皮癌
    　　（8）腺様嚢胞癌様胸腺癌
    　　（9）腸型腺癌　
    　　（10）腺癌，NOS　
    　　（11）腺扁平上皮癌　
    　　（12）肉腫様癌
    　　（13）未分化癌　
    　II．胸腺神経内分泌腫瘍
    　III．胚細胞腫瘍
    　IV．血液・リンパ増殖性病変
    　V．神経原性腫瘍
    　VI．胸腺および縦隔の軟部腫瘍
    　VII．転移性腫瘍
    　VIII．腫瘍様病変，過誤腫
    　　1．嚢胞性病変
    　　2．増殖性病変（胸腺過形成・異所性過誤腫性胸腺腫）
    　　3．異所性甲状腺・異所性副甲状腺病変

    第3部　鑑別ポイント
    　I．生検標本の診断
    　II．胸腺腫の浸潤の評価（臨床との応用）　
    　III．B3型胸腺腫と胸腺癌の鑑別
    　IV．混合型胸腺上皮性腫瘍の診断
    　V．嚢胞性病変の鑑別診断

    第4部　臨床との連携
    　I．術前診断
    　II．臨床病態
    　III．治療
    　IV．病理診断報告書の記載

    ［胸膜腫瘍］
    第1部　検鏡前の確認事項
    　I．中皮腫瘍取扱い規約とWHO分類 第5版（2021）のコンセプト
    　II．病理標本の扱い方
    　　1．胸膜生検, 細胞診セルブロック
    　　2．手術材料の取扱い　

    第2部　組織型と診断の実際　
    　I．中皮細胞腫瘍
    　　1．良性腫瘍と前浸潤性病変
    　　（1）アデノマトイド腫瘍
    　　（2）高分化乳頭状中皮腫瘍
    　　（3）Mesothelioma in situ（前浸潤性中皮腫）
    　　2．悪性腫瘍
    　　（1）びまん性中皮腫（上皮型, 肉腫型（線維形成性を含む）, 二相型）
    　　（2）局在型中皮腫　
    　II．リンパ腫
    　　1．原発性体腔液リンパ腫
    　　2．慢性炎症関連びまん性大細胞型B細胞リンパ腫
    　III．転移性腫瘍　
    　IV．非上皮性腫瘍
    　V．腫瘍様病変

    第3部　鑑別ポイント
    　I．反応性中皮増殖と中皮腫の鑑別
    　II．中皮腫と肺癌の胸膜浸潤との鑑別　

    第4部　臨床との連携
    　I．中皮腫の画像所見
    　II．細胞診の有用性
    　III．中皮腫の治療
    　IV．病理診断報告書の記載
    　　1．生検検体
    　　2．手術検体

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

[ 縦隔腫瘍 ]

P.6 掲載の参考文献
1) 日本胸腺研究会 (編) : 臨床・病理 縦隔腫瘍取扱い規約, 第1版, 金原出版, 2009
 
2) Rosai J, Sobin LH : World Health Organization International Histological Classification of Tumours, Histological Typing of Tumours of the Thymus (2nd ed), Springer, Berlin, 1999
 
3) Travis WD, Brambilla E, Muller-Hermelink HK, et al (eds) : WHO Classification of Tumours, Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (3rd ed.), IARC, Lyon, 2004
 
4) Travis WD, Brambilla E, Burke AP, et al (eds) : WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart (4th ed.), IARC, Lyon, 2015
 
5) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours, Thoracic tumours (5th ed.), IARC, Lyon, 2021
 
6) Marx A, Strobel P, Badve SS, et al : ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma : refined definitions, histological criteria, and reporting. J Thorac Oncol 9 : 596-611, 2014
PubMed
7) 松野吉宏 : 胸腺腫瘍におけるupdate. 病理と臨床 39 : 693-699, 2021
Medical*Online
8) Shimosato Y, Mukai K, Matsuno Y : AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Mediastinum, AFIP, Washington DC, 2010
 
9) Bernatz PE, Harrison EG, Clagett OT : Thymoma : a clinicopathologic study. J Thorac Cardiovasc Surg 42 : 424-444, 1961
PubMed
10) Shimosato Y, Kameya T, Nagai K, et al : Squamous cell carcinoma of the thymus. An analysis of eight cases. Am J Surg Pathol 1 : 109-121, 1977
 
11) Marino M, Muller-Hermelink HK : Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol 407 : 119-149, 1985
 
12) 向井清 : 胸腺上皮性腫瘍の分類 : 新WHO分類の作成経過. 病理と臨床 20 : 576-581, 2002
 
P.14 掲載の参考文献
1) 日本胸腺研究会 (編) : 臨床・病理 縦隔腫瘍取扱い規約, 第1版, 金原出版, 2009
 
2) Brierley JD, Gospodarowicz MK, Wittekind C (eds) : TNM Classification of Malignant Tumours (8th ed.), Wiley-Blackwell, Hoboken, 2017
 
3) International Collaboration on Cancer Reporting : Thymic Epithelial Tumours Histopathology Reporting Guide. http://www.iccr-cancer.org/getattachment/Datasets/Published-Datasets/Thorax/Thymic-Epithelial-Tumours/ICCR-Thymic-bookmarked-guide-2nd-edition-v2-0-with-notes.pdf (2022年3月閲覧)
 
4) 長谷川千花子, 横瀬智之 : 胸腺腫瘍の被膜浸潤・微小浸潤. 病理と臨床 28 (臨増) : 70-71, 2010
 
5) 日本臨床細胞学会 (編) : がんゲノム診療における細胞検体の取扱い指針, 第1.0版, 2021, pp19-22
 
6) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours, Thoracic Tumours (5th ed.), IARC, Lyon, 2021
 
7) Marx A, Belharazem D, Lee DH, et al : Molecular pathology of thymomas : implications for diagnosis and therapy. Virchows Arch 478 : 101-110, 2021
PubMed
8) 日本病理学会 (編) : ゲノム研究用・診療用病理組織検体取扱い規程, 羊土社, 2019
 
P.29 掲載の参考文献
1) 中智昭, 外丸詩野, 松野吉宏 : 胸腺. 病理と臨床 35 (臨増) : 151-160, 2017
 
2) Strobel P, Hartmann E, Rosenwald A, et al : Corticomedullary differentiation and maturational arrest in thymomas. Histopathology 64 : 557-566, 2014
PubMed
3) Radovich M, Pickering CR, Felau I, et al : The integrated genomic landscape of thymic epithelial tumors. Cancer Cell 33 : 244-258.e10, 2018
 
4) Petrini I, Meltzer PS, Kim IK, et al : A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. Nat Genet 46 : 844-849, 2014
PubMed
5) Detterbeck FC : Clinical value of the WHO classification system of thymoma. Ann Thorac Surg 81 : 2328-2334, 2006
PubMed
6) Vladislav IT, Gokmen-Polar Y, Kesler KA, et al : The role of histology in predicting recurrence of type A thymomas : a clinicopathologic correlation of 23 cases. Mod Pathol 26 : 1059-1064, 2013
PubMed
7) Green AC, Marx A, Strobel P, et al : Type A and AB thymomas : histological features associated with increased stage. Histopathology 66 : 884-891, 2015
PubMed
8) Radovich M, Solzak JP, Hancock BA, et al : A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas. Br J Cancer 114 : 477-484, 2016
PubMed
9) Weis CA, Yao X, Deng Y, et al : The impact of thymoma histotype on prognosis in a worldwide database. J Thorac Oncol 10 : 367-372, 2015
 
10) Okumura M, Ohta M, Tateyama H, et al : The World Health Organization histologic classification system reflects the oncologic behavior of thymoma : a clinical study of 273 patients. Cancer 94 : 624-632, 2002
PubMed
11) Strobel P, Bauer A, Puppe B, et al : Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas : a retrospective analysis. J Clin Oncol 22 : 1501-1509, 2004
PubMed
12) Massoth LR, Hung YP, Dias-Santagata D, et al : Pan-cancer landscape analysis reveals recurrent KMT2A-MAML2 gene fusion in aggressive histologic subtypes of thymoma. JCO Precis Oncol 4 : PO.19.00288, 2020
 
13) Stachowicz-Stencel T, Orbach D, Brecht I, et al : Thymoma and thymic carcinoma in children and adolescents : a report from the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT). Eur J Cancer 51 : 2444-2452, 2015
 
14) de Jong WK, Blaauwgeers JL, Schaapveld M, et al : Thymic epithelial tumours : a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer 44 : 123-130, 2008
PubMed
15) Penzel R, Hoegel J, Schmitz W, et al : Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka. Int J Cancer 105 : 494-498, 2003
PubMed
16) Zettl A, Strobel P, Wagner K, et al : Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol 157 : 257-266, 2000
PubMed
17) Girard N, Shen R, Guo T, et al : Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin Cancer Res 15 : 6790-6799, 2009
PubMed
18) Petrini I, Rajan A, Pham T, et al : Whole genome and transcriptome sequencing of a B3 thymoma. PLoS One 8 : e60572
PubMed
19) Petrini I, Meltzer PS, Zucali PA, et al : Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors. Cell Death Dis 19 : e351, 2012
 
P.39 掲載の参考文献
1) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours, Thoracic Tumours (5th ed.), IARC, Lyon, 2021
 
2) Suster S, Moran CA : Micronodular thymoma with lymphoid B-cell hyperplasia : clinicopathologic and immunohistochemical study of eighteen cases of a distinctive morphologic variant of thymic epithelial neoplasm. Am J Surg Pathol 23 : 955-962, 1999
PubMed
3) Strobel P, Marino M, Feuchtenberger M, et al : Micronodular thymoma : an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development. J Pathol 207 : 72-82, 2005
PubMed
4) Ishikawa Y, Tateyama H, Yoshida M, et al : Micronodular thymoma with lymphoid stroma : an immunohistochemical study of the distribution of Langerhans cells and mature dendritic cells in six patients. Histopathology 66 : 300-307, 2015
PubMed
5) Radovich M, Pickering CR, Felau I, et al : The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell 33 : 244-258.e10, 2018
 
6) Tateyama H, Saito Y, Fujii Y, et al : The spectrum of micronodular thymic epithelial tumours with lymphoid B-cell hyperplasia. Histopathology 38 : 519-527, 2001
PubMed
7) Mneimneh WS, Gokmen-Polar Y, Kesler KA, et al : Micronodular thymic neoplasms : case series and literature review with emphasis on the spectrum of differentiation. Mod Pathol 28 : 1415-1427, 2015
PubMed
8) Suster S, Moran CA, Chan JK : Thymoma with pseudosarcomatous stroma : report of an unusual histologic variant of thymic epithelial neoplasm that may simulate carcinosarcoma. Am J Surg Pathol 21 : 1316-1323, 1997
PubMed
9) Yoneda S, Marx A, Heimann S, et al : Low-grade metaplastic carcinoma of the thymus. Histopathology 35 : 19-30, 1999
 
10) Yoneda S, Marx A, Muller-Hermelink H : Low-grade metaplastic carcinomas of the thymus : biphasic thymic epithelial tumors with mesenchymal metaplasia--an update. Pathol Res Pract 195 : 555-563, 1999
PubMed
11) Liu B, Rao Q, Zhu Y, et al : Metaplastic thymoma of the mediastinum. A clinicopathologic, immunohistochemical, and genetic analysis. J Am J Clin Pathol 137 : 261-269, 2012
PubMed
12) Vivero M, Davineni P, Nardi V, et al : Metaplastic thymoma : a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions. Mod Pathol 33 : 560-565, 2020
PubMed
13) Moritani S, Ichihara S, Mukai K, et al : Sarcomatoid carcinoma of the thymus arising in metaplastic thymoma. Histopathology 52 : 409-411, 2008
PubMed
14) Lu HS, Gan MF, Zhou T, et al : Sarcomatoid thymic carcinoma arising in metaplastic thymoma : a case report. Int J Surg Pathol 19 : 677-680, 2011
 
15) Kuo T, Shih LY : Histologic types of thymoma associated with pure red cell aplasia : a study of five cases including a composite tumor of organoid thymoma associated with an unusual lipofibroadenoma. Int J Surg Pathol 9 : 29-35, 2001
PubMed
16) Wang YL, Yi XH, Chen G, et al : Thymoma associated with an lipofibroadenoma : report of a case. Zhonghua Bing Li Xue Za Zhi 38 : 556-557, 2009
PubMed
17) Hui M, Paul TR, Uppin SG, et al : Lipofibroadenoma with B1 thymoma : A case report of a rare thymic tumor. J Pathol Microbiol 61 : 630-632, 2018
 
18) Rosai J, Levine GD : Atlas of Tumor Pathology, Series 2, Tumors of the Thymus, AFIP, Washington DC, 1976
 
19) Pescarmona E, Rosati S, Pisacane A, et al : Microscopic thymoma : histological evidence of multifocal cortical and medullary origin. Histopathology 20 : 263-266, 1992
PubMed
20) Cheuk W, Tsang WY, Chan JK : Microthymoma : definition of the entity and distinction from nodular hyperplasia of the thymic epithelium (so-called microscopic thymoma). Am J Surg Pathol 29 : 415-419, 2005
PubMed
21) Kuo T : Sclerosing thymoma-a possible phenomenon of regression. Histopathology 25 : 289-291, 1994
PubMed
22) Moran CA, Suster S : "Ancient" (sclerosing) thymomas : a clinicopathologic study of 10 cases. Am J Clin Pathol 121 : 867-871, 2004
PubMed
P.45 掲載の参考文献
1) Chan JKC, Chen G, Molina TJ, et al : Squamous cell carcinoma of the thymus. in WHO Classification of Tumours Editorial Board (ed) "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp354-358
 
2) Shimosato Y, Mukai K, Matsuno Y : AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Mediastinum, AFIP, Washington DC, 2010
 
3) Ahmad U, Yao X, Detterbeck F, et al : Thymic carcinoma outcomes and prognosis : results of an international analysis. J Thorac Cardiovasc Surg 149 : 95-100, 101.e1-2, 2015
 
4) Weksler B, Dhupar R, Parikh V, et al : Thymic carcinoma : a multivariate analysis of factors predictive of survival in 290 patients. Ann Thorac Surg 95 : 299-303, 2013
PubMed
5) Suster S, Moran CA : Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases. Am J Surg Pathol 20 : 1469-1480, 1996
PubMed
6) Yamada Y, Tomaru U, Ishizu A, et al : Expression of proteasome subunit β5t in thymic epithelial tumors. Am J Surg Pathol 35 : 1296-1304, 2011
 
7) Nonaka D, Henley JD, Chiriboga L, et al : Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms. Am J Surg Pathol 31 : 1038-1044, 2007
PubMed
8) Marchevsky AM, Walts AE : PD-L1, PD-1, CD4, and CD8 expression in neoplastic and nonneoplastic thymus. Hum Pathol 60 : 16-23, 2017
PubMed
9) Girard N, Shen R, Guo T, et al : Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin Cancer Res 15 : 6790-6799, 2009
PubMed
10) Sakane T, Murase T, Okuda K, et al : A mutation analysis of the EGFR pathway genes, RAS, EGFR, PIK3CA, AKT1 and BRAF, and TP53 gene in thymic carcinoma and thymoma type A/B3. Histopathology 75 : 755-766, 2019
PubMed
11) Strobel P, Hartmann M, Jakob A, et al : Thymic carcinoma with overexpression of mutated KIT and the response to imatinib. N Engl J Med 350 : 2625-2626, 2004
PubMed
P.48 掲載の参考文献
1) Snover DC, Levine GD, Rosai J : Thymic carcinoma. Five distinctive histological variants. Am J Surg Pathol 6 : 451-470, 1982
PubMed
2) Brown JG, Familiari U, Papotti M, et al : Thymic basaloid carcinoma : a clinicopathologic study of 12 cases, with a general discussion of basaloid carcinoma and its relationship with adenoid cystic carcinoma. Am J Surg Pathol 33 : 1113-1124, 2009
PubMed
3) Papotti M, Marx A, Mukai K, et al : Basaloid carcinoma of the thymus. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp359-360
 
4) Suster S, Rosai J : Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer 67 : 1025-1032, 1991
PubMed
5) Ahmad U, Yao X, Detterbeck F, et al : Thymic carcinoma outcomes and prognosis : results of an international analysis. J Thorac Cardiovasc Surg 149 : 95-100, 101. e1-2, 2015
 
6) Sakakura N, Tateyama H, Usami N, et al : Thymic basaloid carcinoma with pleural dissemination that developed after a curative resection : report of a case. Surg Today 40 : 1073-1078, 2010
PubMed
P.50 掲載の参考文献
1) Ahmad U, Yao X, Detterbeck F, et al : Thymic carcinoma outcomes and prognosis : results of an international analysis. J Thorac Cardiovasc Surg 149 : 95-100, 101. e1-2, 2015
 
2) Hishida T, Nomura S, Yano M, et al : Long-term outcome and prognostic factors of surgically treated thymic carcinoma : results of 306 cases from a Japanese Nationwide Database Study. Eur J Cardiothorac Surg 49 : 835-841, 2016
PubMed
3) Chan JKC, Chalabreysse L, Mukai K, et al : Lymphoepithelial carcinoma of the thymus thoracic tumours. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumors, Thoracic Tumours" (5th ed.), IARC, Lyon, 2021, pp361-363
 
4) Suster D, Pihan G, Mackinnon AC, et al : Expression of PD-L1/PD-1 in lymphoepithelioma-like carcinoma of the thymus. Mod Pathol 31 : 1801-1806, 2018
PubMed
P.53 掲載の参考文献
1) French CA, Miyoshi I, Kubonishi I, et al : BRD4-NUT fusion oncogene : a novel mechanism in aggressive carcinoma. Cancer Res 63 : 304-307, 2003
PubMed
2) Chau NG, Ma C, Danga K, et al : An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma : analysis of 124 patients. JNCI Cancer Spectr 4 : pkz094, 2019
PubMed
3) Evans AG, French CA, Cameron MJ, et al : Pathologic characteristics of NUT midline carcinoma arising in the mediastinum. Am J Surg Pathol 36 : 1222-1227, 2012
PubMed
4) French CA, Kutok JL, Faquin WC, et al : Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 22 : 4135-4139, 2004
 
5) Stelow EB, Bellizzi AM, Taneja K, et al : NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol 32 : 828-834, 2008
PubMed
6) U.S. National Library of Medicin, ClinicalTrials.gov [Internet] : BI894999 first in human dose finding study in advanced malignancies. first posted 2015 Aug 6 [updated 2020 Aug 12] https://clinicaltrials.gov/ct2/show/NCT02516553 (2022年3月閲覧)
 
7) Haack H, Johnson LA, Fry CJ, et al : Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 33 : 984-991, 2009
PubMed
8) Hung YP, Chen AL, Taylor MS, et al : Thoracic nuclear protein in testis (NUT) carcinoma : expanded pathological spectrum with expression of thyroid transcription factor-1 and neuroendocrine markers. Histopathology 78 : 896-904, 2021
PubMed
9) Lee JK, Louzada S, An Y, et al : Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma. Ann Oncol 28 : 890-897, 2017
PubMed
10) Alekseyenko AA, Walsh EM, Wang X, et al : The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains. Genes Dev 29 : 1507-1523, 2015
PubMed
P.55 掲載の参考文献
1) Clear cell carcinoma of the thymus. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, L yon, 2021, p368
 
2) Hasserjian RP, Klimstra DS, Rosai J : Carcinoma of the thymus with clear-cell features. Report of eight cases and review of the literature. Am J Surg Pathol 19 : 835-841, 1995
 
3) Porubsky S, Rudolph B, Ruckert JC, et al : EWSR1 translocation in primary hyalinising clear cell carcinoma of the thymus. Histopathology 75 : 431-436, 2019
PubMed
P.58 掲載の参考文献
1) Marino M, Marx A, Matsuno Y, et al : Low-grade papillary adenocarcinoma of the thymus. in WHO Classification of Tumours Editorial Board (ed) "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp370-371
 
2) Matsuno Y, Morozumi N, Hirohashi S, et al : Papillary carcinoma of the thymus : report of four cases of a new microscopic type of thymic carcinoma. Am J Surg Pathol 22 : 873-880, 1998
PubMed
3) Hosaka Y, Tsuchida M, Umezu H, et al : Primary thymic adenocarcinoma coexisting with type AB thymoma : a rare case with long-term survival. Gen Thorac Cardiovasc Surg 58 : 488-491 ; discussion 491-492, 2010
 
4) Oka S, Inoue M, Honda Y, et al : Thymic papillary adenocarcinoma coexisting with type A thymoma : A case report. Int J Surg Case Rep 57 : 142-144, 2019
PubMed
5) Weissferdt A, Moran CA : Thymic carcinoma associated with multilocular thymic cyst : a clinicopathologic study of 7 cases. Am J Surg Pathol 35 : 1074-1079, 2011
PubMed
6) Yoshino M, Hiroshima K, Motohashi S, et al : Papillary carcinoma of the thymus gland. Ann Thorac Surg 80 : 741-742, 2005
PubMed
7) 松野吉宏 : 乳頭状線癌. 深山正久, 野口雅之, 松野吉宏 (編) : 腫瘍病理鑑別診断アトラス 縦隔腫瘍・胸膜腫瘍, 第1版, 文光堂, 2014, pp57-58
 
P.60 掲載の参考文献
1) Moran CA, Suster S : Mucoepidermoid carcinomas of the thymus. A clinicopathologic study of six cases. Am J Surg Pathol 19 : 826-834, 1995
 
2) Hamza A, Younes AI, Kalhor N : Thymic mucoepidermoid carcinoma : a systematic review and meta-analysis. Adv Anat Pathol 26 : 341-345, 2019
PubMed
3) Murase T, Nakano S, Sakane T, et al : Thymic mucoepidermoid carcinoma : A clinicopathologic and molecular study. Am J Surg Pathol (in press)
 
P.62 掲載の参考文献
1) Kalhor N, Weissferdt A, Moran CA : Primary salivary gland type tumors of the thymus. Adv Anat Pathol 24 : 15-23, 2017
PubMed
2) Yang MQ, Bai LL, Wang Z, et al : Primary thymic carcinoma with adenoid cystic carcinoma-like features : A case report and literature review. Medicine 99 : e21531, 2020
PubMed
3) Di Tommaso L, Kuhn E, Kurrer M, et al : Thymic tumor with adenoid cystic carcinomalike features : a clinicopathologic study of 4 cases. Am J Surg Pathol 31 : 1161-1167, 2007
PubMed
4) Rampisela D, Zreik R, Donner LR : Thymic tumor with adenoid cystic carcinoma-like features : A study of a clinically favorable case followed for 9 years. Int J Surg Pathol 23 : 557-560, 2015
PubMed
P.65 掲載の参考文献
1) Choi WW, Lui YH, Lau WH, et al : Adenocarcinoma of the thymus : report of two cases, including a previously undescribed mucinous subtype. Am J Surg Pathol 27 : 124-130, 2003
PubMed
2) Takahashi F, Tsuta K, Matsuno Y, et al : Adenocarcinoma of the thymus : mucinous subtype. Hum Pathol 36 : 219-223, 2005
PubMed
3) Maghbool M, Ramzi M, Nagel I, et al : Primary adenocarcinoma of the thymus : an immunohistochemical and molecular study with review of the literature. BMC Clin Pathol 13 : 17, 2013
PubMed
4) Kalhor N, Moran CA : Primary thymic adenocarcinomas : a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation. Hum Pathol 74 : 73-82, 2018
PubMed
5) Shiono A, Fujino T, Kaira K, et al : Primary thymic adenocarcinoma with an aggressive clinical course : An autopsy case showing signet ring cell-like features. Thorac Cancer 11 : 3609-3613, 2020
PubMed
6) Maeda D, Ota S, Ikeda S, et al : Mucinous adenocarcinoma of the thymus : a distinct variant of thymic carcinoma. Lung Cancer 64 : 22-27, 2009
PubMed
7) Lee Y, Park S, Lee SH, et al : Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma. BMC Cancer 17 : 330, 2017
 
8) Sakanoue I, Hamakawa H, Fujimoto D, et al : KRAS mutation-positive mucinous adenocarcinoma originating in the thymus. J Thorac Dis 9 : E694-E697, 2017
PubMed
9) Akiba J, Harada H, Yokoyama S, et al : Mucinous cystic tumor with CK20 and CDX2 expression of the thymus : Is this a benign counterpart of adenocarcinoma of the thymus, enteric type? Pathol Int 66 : 29-33, 2016
 
P.67 掲載の参考文献
1) Kalhor N, Moran CA : Primary thymic adenocarcinomas : a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation. Hum Pathol 74 : 73-82, 2018
PubMed
2) Roxas RBS, Bernardo MCF, Jacoba AP, et al : Primary thymic signet ring cell adenocarcinoma : a currently unrecognized variant. Int J Surg Pathol 27 : 315-321, 2019
PubMed
P.69 掲載の参考文献
1) de Queiroga EM, Chikota H, Bacchi CE, et al : Rhabdomyomatous carcinoma of the thymus. Am J Surg Pathol 28 : 1245-1250, 2004
PubMed
2) Matsuno Y, Mukai K, Noguchi M, et al : Histochemical and immunohistochemical evidence of glandular differentiation in thymic carcinoma. Acta Pathol Jpn 39 : 433-438, 1989
PubMed
P.72 掲載の参考文献
1) Snover DC, Levine GD, Rosai J : Thymic carcinoma. Five distinctive histological variants. Am J Surg Pathol 6 : 451-470, 1982
PubMed
2) Marino M, Di Tommaso L, Mukai K : Sarcomatoid carcinoma of the thymus. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp383-385
 
3) Ahmad U, Yao X, Dettebeck F, et al : Thymic carcinoma outcomes and prognosis : results of an international analysis. J Thorac Cardiovasc Surg 149 : 95-100, 101.e1-2, 2015
 
4) Suster S, Moran CA : Spindle cell thymic carcinoma : clinicopathologic and immunohistochemical study of a distinctive variant of primary thymic epithelial neoplasm. Am J Surg Pathol 23 : 691-700, 1999
PubMed
5) Eimoto T, Kitaoka M, Ogawa H, et al : Thymic sarcomatoid carcinoma with skeletal muscle differentiation : report of two cases, one with cytogenetic analysis. Histopathology 40 : 46-57, 2002
PubMed
6) Vivero M, Davineni P, Nardi V, et al : Metaplastic thymoma : a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions. Mod Pathol 33 : 560-565, 2020
PubMed
7) Moritani S, Ichihara S, Mukai K, et al : Sarcomatoid carcinoma of the thymus arising in metaplastic thymoma. Histopathology 52 : 409-411, 2008
PubMed
P.73 掲載の参考文献
1) Undifferentiated carcinoma of the thymus. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, p386
 
2) Ahmad U, Yao X, Detterbeck F, et al : Thymic carcinoma outcomes and prognosis : results of an international analysis. J Thorac Cardiovasc Surg 149 : 95-100, 101. e1-2, 2015
 
P.80 掲載の参考文献
1) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours, Thoracic Tumours (5th ed.), IARC, Lyon, 2021
 
2) Dinter H, Bohnenberger H, Beck J et al : Molecular classification of neuroendocrine tumors of the thymus. J Thorac Oncol 14 : 1472-1483, 2019
PubMed
3) Bohnenberger H, Strobel P : Recent advances and conceptual changes in the classification of neuroendocrine tumors of the thymus. Virchows Arch 478 : 129-135, 2021
PubMed
4) Hishima T, Fukayama M, Hayashi Y, et al : Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma. HumPathol 29 : 330-338, 1998
PubMed
5) Rieker RJ, Aulmann S, Penzel R et al : Chromosomal imbalances in sporadic neuroendocrine tumours of the thymus. Cancer Lett 223 : 169-174, 2005
PubMed
6) Strobel P, Zettl A, Shilo K, et al : Tumor genetics and survival of thymic neuroendocrine neoplasms : a multi-institutional clinicopathologic study. Genes Chromosomes Cancer 53 : 738-749, 2014
PubMed
7) Weissferdt A, Tang X, Wistuba II, et al : Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1. Mod Pathol 26 : 1554-1560, 2013
PubMed
8) Ose N, Maeda H, Inoue M, et al : Results of treatment for thymic neuroendocrine tumours : multicentre clinicopathological study. Interact Cardiovasc Thorac Surg 26 : 18-24, 2018
PubMed
9) Rindi G, Klimstra DS, Abedi-Ardekani B, et al : A common classification framework for neuroendocrine neoplasms : an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31 : 1770-1786, 2018
PubMed
10) Bi Y, Deng Y, Li S, et al : Immunophenotypic and prognostic analysis of PAX8 and TTF-1 expressions in neuroendocrine carcinomas of thymic origin : A comparative study with their pulmonary counterparts. J Surg Oncol 114 : 697-702, 2016
PubMed
P.90 掲載の参考文献
1) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours, Thoracic Tumours (5th ed.), IARC, Lyon, 2021, p401
 
2) Roden AC, Chan JKC, Ulbright TM : Seminoma of the mediastinum. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp402-404
 
3) 松野吉宏 : 縦隔腫瘍. 深山正久, 森永正二郎, 小田義直ほか (編) : 外科病理学, 2020, pp379-411
 
4) Shimosato Y, Mukai K, Matsuno Y : AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Mediastinum, AFIP, Washington DC, 2010, pp193-224
 
5) Sung MT, Maclennan GT, Lopez-Beltran A, et al : Primary mediastinal seminoma : a comprehensive assessment integrated with histology, immunohistochemistry, and fluorescence in situ hybridization for chromosome 12p abnormalities in 23 cases. Am J Surg Pathol 32 : 146-155, 2008
PubMed
6) Przygodzki RM, Hubbs AE, Zhao FQ, et al : Primary mediastinal seminomas : evidence of single and multiple KIT mutations. Lav Invest 82 : 1369-1375, 2002
 
7) Roden AC, Marx A, Ulbright TM : Embryonal carcinoma of the mediastinum. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp405-406
 
8) Marx A, Marom EM, Moreira AL et al : Yolk sac tumour of the mediastinum. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp407-411
 
9) Schneider DT, Schuster AE, Fritsch MK, et al : Genetic analysis of mediastinal nonseminomatous germ cell tumors in children and adolescents. Genes Chromosomes Cancer 34 : 115-125, 2002
PubMed
10) Strobel P, Moreira AL : Choriocarcinoma of the mediastinum. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp412-413
 
11) Chaganti RS, Rodriguez E, Mathew S : Origin of adult male mediastinal germ-cell tumours. Lancet 343 : 1130-1132, 1994
PubMed
12) Moreira AL, Roden AC, Strobel P, Ulbright TM : Teratoma of the mediastinum. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp414-416
 
13) Nakajima E, Kudo Y, Maehara S, et al : Ruptured mediastinal mature teratoma causing severe mediastinitis : report of a surgically resected case and a literature review. Surg Case Rep 7 : 48, 2021
 
14) Dulmet EM, Macchiarini P, Suc B, et al : Germ cell tumors of the mediastinum. A 30-year experience. Cancer 72 : 1894-1901, 1993
PubMed
15) Kao CS, Bangs CD, Aldrete G, et al : A clinicopathologic and molecular analysis of 34 mediastinal germ cell tumors suggesting different modes of teratoma development. Am J Surg Pathol 42 : 1662-1673, 2018
PubMed
16) Moreira AL, Roden AC, Strobel P et al : Mixed germ cell tumours of the mediastinum. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp417-418
 
17) Roden AC, Strobel P, Ulbright TM : Mediastinal germ cell tumours with somatic-type solid malignancy. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp419-421
 
18) Malagon HD, Valdez AM, Moran CA, et al : Germ cell tumors with sarcomatous components : a clinicopathologic and immunohistochemical study of 46 cases. Am J Surg Pathol 31 : 1356-1362, 2007
PubMed
19) Motzer RJ, Amsterdam A, Prieto V, et al : Teratoma with malignant transformation : diverse malignant histologies arising in men with germ cell tumors. J Urol 159 : 133-138, 1998
PubMed
20) Kum JB, Ulbright TM, Willamson SF, et al : Molecular genetic evidence supporting the origin of somatic-type malignancy and teratoma from the same progenitor cell. Am J Surg Pathol 36 : 1849-1856, 2012
 
21) Orazi A, Moreira AL, Roden AC : Mediastinal germ cell tumours with associated haematological malignancy. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp422-423
 
22) Molzer RJ, Amsterdam A, Prieto V, et al : Teratoma with malignant transformation : diverse malignant histologies arising in men with germ cell tumors. J Urol 159 : 133-138, 1998
 
23) Ladanyi M, Samaniego F, Reuter VE, et al : Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Inst 82 : 221-227, 1990
PubMed
P.102 掲載の参考文献
1) Maeshima AM, Taniguchi H, Suzuki T, et al : Distribution of malignant lymphomas in the anterior mediastinum : a single-institution study of 76 cases in Japan, 1997-2016. Int J Hematol 106 : 675-680, 2017
PubMed
2) Xu X, Paxton CN, Hayashi RJ, et al : Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma. Blood Adv 27 : 2890-2900, 2021
 
3) Li S, Juco J, Mann KP, et al : Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. Am J Clin Pathol 121 : 268-274, 2004
PubMed
4) Fichtner A, Richter A, Filmar S, et al : Primary mediastinal germ cell tumours : an immunohistochemical and molecular diagnostic approach. Histopathology 80 : 381-396, 2022
PubMed
5) Brobeil A, Wagenlehner F, Gattenlohner S : Expression of terminal deoxynucleotidyl transferase (TdT) in classical seminoma : a potential diagnostic pitfall. Virchows Arch 472 : 433-440, 2018
PubMed
6) Roemer MG, Advani RH, Ligon AH, et al : PD-L1 and PDL2 genetic alterations define classical Hodgkin lymphoma and predict outcome. J Clin Oncol 34 : 2690-2697, 2016
 
7) 中村直哉 : リンパ節. 病理と臨床 39 (臨増) : 191-197, 2021
 
8) Green MR, Monti S, Rodig SJ, et al : Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 116 : 3268-3277, 2010
 
9) Savage KJ : Primary mediastinal large B-cell lymphoma. Blood, 2021, doi : 10.1182/blood.2020008376. online ahead of print
 
10) Sarkozy C, Molina T, Ghesquieres H, et al : Mediastinal gray zone lymphoma : clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association. Haematologica 102 : 150-159, 2017
PubMed
11) Pilichowska M, Pittaluga S, Ferry JA, et al : Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. Blood Adv 1 : 2600-2609, 2017
 
12) Sarkozy C, Chong L, Takata K, et al : Gene expression profiling of gray zone lymphoma. Blood Adv 4 : 2523-2535, 2020
PubMed
13) Sarkozy C, Hung SS, Chavez EA, et al : Mutational landscape of gray zone lymphoma.Blood 137 : 1765-1776, 2021
PubMed
14) Wang X, Miao Y, Cao Z, et al : Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma. Ann Hematol 101 : 91-97, 2022
PubMed
15) 稲垣宏, 正木彩子 : 悪性リンパ腫. 腫瘍病理鑑別診断アトラス 縦隔腫瘍・胸膜腫瘍, 第1版, 文光堂, pp83-98
 
16) Wu YL, Wu F, Xu CP, et al : Mediastinal follicular dendritic cell sarcoma : a rare, potentially under-recognized, and often misdiagnosed disease. Diagn Pathol 14 : 5, 2019
PubMed
17) Griffin GK, Sholl LM, Lindeman NI, et al : Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-κB regulatory genes. Mod Pathol 29 : 67-74, 2016
 
18) Fajgenbaum DC, Uldrick TS, Bagg A, et al : International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood 129 : 1646-1657, 2017
PubMed
P.109 掲載の参考文献
1) Duwe BV, Sterman DH, Musani AI : Tumors of the mediastinum. Chest 128 : 2893-2909, 2005
PubMed
2) Strollo DC, Rosado-de-Christenson ML, Jett JR : Primary mediastinal tumors : part II. Tumors of the middle and posterior mediastinum. Chest 112 : 1344-1357, 1997
PubMed
3) Fujimoto K, Hara M, Tomiyama N, et al : Proposal for a new mediastinal compartment classification of transverse plane images according to the Japanese Association for Research on the Thymus (JART) General Rules for the Study of Mediastinal Tumors. Oncol Rep 31 : 565-572, 2014
 
4) 日本内分泌学会 (監), 日本内分泌学会「悪性褐色細胞腫の実態調査と診療指針の作成」委員会 (編) : 褐色細胞腫・パラガングリオーマ診療ガイドライン 2018, 診断と治療社, 2018
 
5) den Bakker MA, Marx A, Mukai K, et al : Mesenchymal tumours of the mediastinum-part II. Virchows Arch 467 : 501-517, 2015
PubMed
6) Topcu S, Alper A, Gulhan E, et al : Neurogenic tumours of the mediastinum : a report of 60 cases. Can Respir J 7 : 261-265, 2000
PubMed
7) Woo OH, Yong HS, Shin BK, et al : Wide spectrum of thoracic eurogenic tumours : a pictorial review of CT and pathological findings. Br J Radiol 81 : 668-676, 2008
 
8) Odze R, Begin LR : Malignant paraganglioma of the posterior mediastinum. A case report and review of the literature. Cancer 65 : 564-569, 1990
PubMed
9) Thompson LD : Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms : a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26 : 551-566, 2002
PubMed
10) Eisenhofer G, Tischler AS, de Krijger RR : Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma : from routine laboratory methods to disease stratification. Endocr Pathol 23 : 4-14, 2012
PubMed
P.116 掲載の参考文献
1) Othman SA, AlFrayyan OY, AlGhamdi ZM, et al : Thymolipoma association with myasthenia gravis : case report. Am J Case Rep 21 : e923989, 2020
PubMed
2) Elliott DRF, Myers JL, Konopka KE : Thymoliposarcoma with sebaceous differentiation and MDM2 amplification. Pathol Int 71 : 633-635, 2021
PubMed
3) Alhames S, Ghabally M : Enbloc resection of the largest thymic liposarcoma : A case report with literature review. Ann Med Surg (Lond) 59 : 204-206, 2020
PubMed
4) Sung MT, Ko SF, Hsieh MJ, et al : Thymoliposarcoma. Ann Thorac Surg 76 : 2082-2085, 2003
PubMed
5) Klimstra DS, Moran CA, Perino G, et al : Liposarcoma of the anterior mediastinum and thymus. A clinicopathologic study of 28 cases. Am J Surg Pathol 19 : 782-791, 1995
 
6) Alaggio R, Creytens D : Myxoid pleomorphic liposarcoma. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Soft Tissue and Bone Tumours" (5 th ed.), IARC, Lyon, 2020, pp47-48
 
7) Ortega P, Suster D, Falconieri G, et al : Liposarcomas of the posterior mediastinum : clinicopathologic study of 18 cases. Mod Pathol 28 : 721-731, 2015
PubMed
8) Hahn HP, Fletcher CD : Primary mediastinal liposarcoma : clinicopathologic analysis of 24 cases. Am J Surg Pathol 31 : 1868-1874, 2007
PubMed
9) Boland JM, Colby TV, Folpe AL : Liposarcomas of the mediastinum and thorax : a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features. Am J Surg Pathol 36 : 1395-1403, 2012
PubMed
10) Sbaraglia M, Dei Tos AP, Pedeutour F, et al : Atypical lipomatous tumor/well-differentiated liposarcoma. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Soft Tissue and Bone Tumours" (5th ed.), IARC, Lyon, 2020, pp36-38
 
11) Alaggio R, Coffin CM, Weiss SW, et al : Liposarcomas in young patients : a study of 82 cases occurring in patients younger than 22 years of age. Am J Surg Pathol 33 : 645-658, 2009
PubMed
P.118 掲載の参考文献
1) Roden AC, Fang W, Shen Y, et al : Distribution of mediastinal lesions across multi-institutional, international, radiology databases. J Thorac Oncol 15 : 568-579, 2020
PubMed
2) Middleton G : Involvement of the thymus by metastatic neoplasms. Br J Cancer 20 : 41-46, 1966
 
3) Nonaka D, Henley JD, Chiriboga L, et al : Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms. Am J Surg Pathol 31 : 1038-1044, 2007
PubMed
4) Bi Y, Deng Y, Li S, et al : Immunophenotypic and prognostic analysis of PAX8 and TTF-1 expressions in neuroendocrine carcinomas of thymic origin : A comparative study with their pulmonary counterparts. J Surg Oncol 114 : 697-702, 2016
PubMed
5) Clark SL : The reticulum of lymph nodes in mice studied with the electron microscope. Am J Anat 110 : 217-257, 1962
PubMed
P.123 掲載の参考文献
1) Shimosato Y, Mukai K, Matsuno Y : Tumors of the mediastinum. in "AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Mediastinum", AFIP, Washingtom DC, 2010, p305
 
2) Takeda S, Miyoshi S, Minami M, et al : Clinical spectrum of mediastinal cysts. Chest 124 : 125-132, 2003
PubMed
3) Juanpere S, Canete N, Ortuno P, et al : A diagnostic aproach to mediastinal masses. Insights Imaging 4 : 29-52, 2013
 
4) Odev K, Aribas BK, Nayman A, et al : Imaging of cystic and cyst-like lesions of the mediastinum with pathologic correlation. J Clin Imaging Sci 2 : 33, 2012
PubMed
5) Raica M, Cimpean AM, Encica S, et al : Involution of the thymus : a posiible diagnostic pitfall. Roma J Morphol Embryol 48 : 101-106, 2007
 
6) Suster S, Rosai J : Multilocular thymic cyst : an acquired reactive process. Study of 18 cases. Am J Surg Pathol 15 : 388-398, 1991
PubMed
7) Nakamura S, Tateyama H, Taniguchi T, et al : Multilocular thymic cyst associated with thymoma : a clinicopathologic study of 20 cases with an emphasis on the pathogenesis of cyst formation. Am J Surg Pathol 36 : 1857-1864, 2012
PubMed
8) Weissferdt A, Moran C : Thymic carcinoma associated with multilocular thymic cyst : a clinicopathologic study of 7 cases. Am J Surg Pathol 35 : 1047-1079, 2011
 
9) 比島恒和 : 嚢胞性病変. 深山正久, 野口雅之, 松野吉宏 (編) : 腫瘍病理鑑別診断アトラス 縦隔腫瘍・胸膜腫瘍, 第1版, 文光堂, 2014, pp111-115
 
10) Limaiem F, Ayadi-Kaddour A, Djilani H, et al : Pulmonary and mediastinal bronchogenic cysts : a clinicopathologic study of 33 cases. Lung 186 : 55-61, 2008
PubMed
11) Menezes AH, Traynelis VC : Spinal neurenteric cysts in the magnetic resonance imaging era. Neurosurgery 58 : 97-105, 2006
PubMed
12) InoueT, Matsushima T, Fukui M, et al : Immunohistochemical study of intracranial cysts. Neurosurgery 23 : 576-581, 1988
 
13) Cangemi V, Volpino P, Gualdi G, et al : Pericardial cysts of the mediastinum. J Cardiovasc Surg 40 : 909-913, 1999
PubMed
P.128 掲載の参考文献
1) Shimosato Y, Mukai K, Matsuno Y : Non-neoplastic conditions of the thymus. in Shimosato Y, Mukai K, Matsuno Y (eds) : "AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Mediastinum", AFIP, Washington DC, 2010
 
2) Nicolaou S, Muller NL, Li DK, et al : Thymus in myasthenia gravis : comparison of CT and pathologic findings and clinical outcome after thymectomy. Radiology 201 : 471-474, 1996
PubMed
3) Marchevsky AM, Wick MR (eds) : Pathology of the Mediastinum, Cambridge University Press, Cambridge, 2014
 
4) Thompson LDR, Gagan J, Washington A, et al : Biphenotypic Branchioma : a better name than ectopic hamartomatous thymoma for a neoplasm with HRAS mutation. Head Neck Pathol 14 : 884-888, 2020
PubMed
5) Rosai J, Limas C, Husband EM : Ectopic hamartomatous thymoma. A distinctive benign lesion of lower neck. The Am J Surg Pathol 8 : 501-513, 1984
 
6) Sato K, Thompson LDR, Miyai K, et al : Ectopic hamartomatous thymoma : a review of the literature with report of new cases and proposal of a new name : biphenotypic branchioma. Head Neck Pathol 12 : 202-209, 2018
PubMed
7) Weinreb I, O'Malley F, Ghazarian D : Ectopic hamartomatous thymoma : a case demonstrating skin adnexal differentiation with positivity for epithelial membrane antigen, androgen receptors, and BRST-2 by immunohistochemistry. Hum pathol 38 : 1092-1095, 2007
 
8) Michal M, Zamecnik M, Gogora M, et al : Pitfalls in the diagnosis of ectopic hamartomatous thymoma. Histopathology 29 : 549-555, 1996
 
9) Liang PI, Li CF, Sato Y, et al : Ectopic hamartomatous thymoma is distinct from lipomatous pleomorphic adenoma in lacking PLAG1 aberration. Histopathology 62 : 518-522, 2013
PubMed
P.132 掲載の参考文献
1) Shimosato Y, Mukai K, Matsuno Y : Ectopic tissue and tumors in the anterosuperior mediastinum. in Shimosato Y, Mukai K, Matsuno Y (eds) : "AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Mediastinum", AFIP, Washington DC, 2010, pp281-284
 
2) Sadler TW (原著), 安田峯生, 山田重人 (訳) : ラングマン人体発生学, 第11版 (原書第13版), メディカル・サイエンス・インターナショナル, 2016
 
3) Weissferdt A, Chalabreysse L, Weis C : Ectopic thyroid tumours, Ectopic parathyroid tumours. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp446-449
 
4) Marchevsky AM, Wick MR : Pathology of the Mediastinum, Cambridge University Press, Cambridge, 2014
 
P.140 掲載の参考文献
1) Tazelaar HD, Roden AC : Pathology of mediastinal tumors. UpToDate(R). https://www.uptodate.com/contents/pathology-of-mediastinal-tumors?search=thymoma%20biopsy&source=search_result&selectedTitle=6~150&usage_type=default&display_rank=6 (2022年3月閲覧)
 
2) 日本肺癌学会 (編) : 肺癌診療ガイドライン 悪性胸膜中皮腫・胸腺腫瘍含む, 2020年版, 金原出版, 2021
 
3) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours, Thoracic Tumours (5th ed.), IARC, Lyon, 2021
 
4) 深山正久, 野口雅之, 松野吉宏 (編) : 腫瘍病理鑑別診断アトラス 縦隔腫瘍・胸膜腫瘍, 第1版, 文光堂, 2014
 
5) Pina-Oviedo S, Moran CA : Primary Mediastinal Classical Hodgkin Lymphoma. Adv Anat Pathol 23 : 285-309, 2016
PubMed
6) Pina-Oviedo S, Moran CA : Primary mediastinal nodal and extranodal non-Hodgkin lymphomas : current concepts, historical evolution, and useful diagnostic approach : Part 1. Adv Anat Pathol 26 : 346-370, 2019
PubMed
7) Pina-Oviedo S, Moran CA : Primary mediastinal nodal and extranodal non-Hodgkin lymphomas : current concepts, historical evolution, and useful diagnostic approach : Part 2. Adv Anat Pathol 26 : 371-389, 2019
PubMed
8) Yamashita T, Watahiki M, Asai K : Mediastinal metastasis of breast cancer mimicking a primary mediastinal tumor. Am J Case Rep 21 : e925275, 2020
PubMed
9) Xiang Y, Tu S, Zhang F : Rapid metastasis of mediastinal solitary fibrous tumor : Report a case. Medicine (Baltimore) 96 : e9307, 2017
PubMed
10) Chen CC, Yeh HZ, Chang CS, et al : Transarterial embolization of metastatic mediastinal hepatocellular carcinoma. World J Gastroenterol 19 : 3512-3516, 2013
 
P.146 掲載の参考文献
1) Masaoka A, Monden Y, Nakahara K, et al : Follow-up study of thymomas with special reference to their clinical stages. Cancer 48 : 2485-2492, 1981
PubMed
2) Sobin LH, Gospodarowicz MK, Wittekind CH (ed) : TNM Classification of Malignant Tumours (7th ed.), Wiley-Blackwell, Hoboken, 2010
 
3) Muller-Hermelink HK, Engel P, Kuo TT, et al : Tumours of the thymus : introduction. in Travis WD, Brambilla E, Muller-Hermelink HK, et al (eds) : "WHO Classification of Tumours, Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart" (3 rd ed.), IARC, Lyon, 2004, pp148-151
 
4) Brierley JD, Gospodarowicz MK, Wittekind C (eds) : TNM Classification of Malignant Tumours (8th ed.), Wiley-Blackwell, Hoboken, 2017
 
5) Detterbeck FC, Stratton K, Giroux D, et al : The IASLC/ITMIG thymic epithelial tumors staging project : proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9 : S65-S72, 2014
PubMed
6) Koga K, Matsuno Y, Noguchi M, et al : A review of 79 thymomas : modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 44 : 359-367, 1994
PubMed
7) Nicholson AG, Detterbeck FC, Marino M, et al : The IASLC/ITMIG thymic epithelial tumors staging project : proposals for the T component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9 : S73-S80, 2014
 
8) Kondo K, Schil PV, Detterbeck FC, et al : The IASLC/ITMIG thymic epithelial tumnors staging project : proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9 : S81-S87, 2014
 
9) Bhora FY, Chen DJ, Detterbeck FC, et al : The ITMIG/IASLC thymic epithelial tumors staging project : a proposed lymph node map for thymic epithelial tumors in the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9 : S88-S96, 2014
 
10) Detterbeck FC, Moran C, Huang J, et al : Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy 6 : S1730-S1738, 2011
PubMed
11) 立山尚, 杉浦浩, 福本紘一 : 縦隔・胸腺. 病理と臨床 26 (臨増) : 207-211, 2008
 
12) 立山尚 : 胸腺腫の浸潤の評価. 深山正久, 野口雅之, 松野吉宏編 : 腫瘍病理鑑別診断アトラス 縦隔腫瘍・胸膜腫瘍, 2014, pp132-137
 
13) Kondo K, Monden Y : Lymphogenous and hematogenous metastasis of thymic epithelial tumors. Ann Thorac Surg 76 : 1859-1864, 2003
PubMed
14) Nakamura S, Tateyama H, Nakanishi K, et al : Pleural invasion depth of disseminated nodules in patients with stage IVa or recurrent thymoma : assessment, curative impact, and surgical outcomes. Ann Surg Oncol 29 : 1829-1837, 2022
PubMed
15) Ruffini E, Fang W, Guerrera F, et al : The international association for the study of lung cancer thymic tumors staging project : the impact of the eighth edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM stage classification of thymic tumors. J Thorac Oncol 15 : 436-447, 2020
 
P.150 掲載の参考文献
1) WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours (5th ed.), IARC, Lyon, 2021
 
2) Yamada Y, Tomaru U, Ihsizu A, et al : Expression of proteasome subunit β5t in thymic epithelial tumors. Am J Surg Pathol 35 : 1296-1304, 2011
 
3) Kojika M, Ishii G, Yoshida J, et al : Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma : diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms. Mod Pathol 22 : 1341-1350, 2009
PubMed
4) Suster S, Moran CA : Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases. Am J Surg Pathol 20 : 1469-1480, 1996
PubMed
5) Yonemori K, Tsuta K, Tateishi U, et al : Diagnostic accuracy of CT-guided percutaneous cutting needle biopsy for thymic tumours. Clin Radiol 61 : 771-775, 2006
PubMed
P.153 掲載の参考文献
1) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours, Thoracic Tumours (5th ed.), IARC, Lyon, 2021
 
2) 日本胸腺研究会 (編) : 臨床・病理 縦隔腫瘍取扱い規約, 第1版, 金原出版, 2009, p57
 
3) Strobel P, Bauer A, Puppe B, et al : Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas : a retrospective analysis. J Clin Oncol 22 : 1501-1509, 2004
PubMed
4) Suster S, Moran CA : Micronodular thymoma with lymphoid B-cell hyperplasia : clinicopathologic and immunohistochemical study of eighteen cases of a distinctive morphologic variant of thymic epithelial neoplasm. Am J Surg Pathol 23 : 955-962, 1999
PubMed
5) Suster D, Pihan G, Mackinnon AC, et al : Poorly differentiated nonkeratinizing squamous cell carcinoma of the thymus : clinicopathologic and molecular genetic study of 25 cases. Am J Surg Pathol 42 : 1224-1236, 2018
PubMed
6) Travis WD, Brambilla E, Burke AP, et al (eds) : WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart (4th ed.), IARC, Lyon, 2015
 
7) Shimosato Y, Mukai K, Matsuno Y : AFIP Atras of Tumor Pathology, Series 4, Tumors of the Mediastinum, AFIP, Washington DC, 2010, pp185-189
 
P.158 掲載の参考文献
1) 深山正久, 森永正二郎 (編) : 外科病理学, 第5版, 文光堂, 2020
 
2) Shimosato Y, Mukai K, Matsuno Y : AFIP Atlas of Tumor Pathology, Series 4, Tumors of the Mediastinum, AFIP, Washington DC, 2010
 
3) Jeung MY, Gasser B, Gangi A, et al : Imaging of cystic masses of the mediastinum. Radiographics 22 : S79-93, 2002
PubMed
4) Takeda S, Miyoshi S, Minami M, et al : Clinical spectrum of mediastinal cysts. Chest 124 : 125-132, 2003
PubMed
5) Suster S, Rosai J : Multilocular thymic cyst : an acquired reactive process. Study of 18 cases. Am J Surg Pathol 15 : 388-398, 1991
PubMed
6) Sugimoto A, Yamada Y, Fujimoto M, et al : A multilocular thymic cyst associated with mediastinal seminoma : evidence for its medullary epithelial origin highlighted by POU2F3-positive thymic tuft cells and concomitant myoid cell proliferation. Virchows Arch 479 : 215-220, 2021
 
7) Moran CA, Suster S. Mediastinal seminomas with prominent cystic changes. A clinicopathologic study of 10 cases. Am J Surg Pathol 19 : 1047-1053, 1995
 
8) Weissferdt A, Moran CA : Thymic carcinoma associated with multilocular thymic cyst : a clinicopathologic study of 7 cases. Am J Surg Pathol 35 : 1074-1079, 2011
PubMed
P.170 掲載の参考文献
1) 藤本公則, 原眞咲, 楠本昌彦ほか : 縦隔腫瘍取扱い規約に基づく縦隔区分の方法と鑑別疾患. 画像診断 29 : 1496-1504, 2009
 
2) Felson B : Chest Roentgenology, WB Saunders, Philadelphia, 1973
 
3) 原眞咲, 楠本昌彦, 酒井文和ほか : 画像診断. 日本胸腺研究会 (編) : 臨床・病理 縦隔腫瘍取扱い規約, 第1版, 金原出版, 2009, pp1-26
 
4) Fujimoto K, Hara M, Tomiyama N, et al : Proposal for a new mediastinal compartment classification of transverse plane images according to the Japanese Association for Research on the Thymus (JART) General Rules for the Study of Mediastinal Tumors. Oncol Rep 31 : 565-572, 2014
 
5) Carter BW, Tomiyama N, Bhora FY, et al : A modern definition of mediastinal compartments. J Thorac Oncol 9 : S97-S101, 2014
PubMed
6) Carter BW, Benveniste MF, Madan R, et al : ITMIG classification of mediastinal compartments and multidisciplinary approach to mediastinal masses. Radiographics 37 : 413-436, 2017
PubMed
7) 藤本公則 : 縦隔腫瘍の画像診断. コンセンサス癌治療 14 : 118-122, 2016
 
8) Fujimoto K, Muller NL : Anterior mediastinal masses. in Muller NL, Silva CIS (eds) : "Imaging of the Chest", Saunders (Elsevier), Philadelphia, 2008, pp1473-1525
 
9) 藤本公則, 佐土原順子, 角明子 : 縦隔腫瘍 胸腺腫以外の前縦隔腫瘍. 村田喜代史, 上甲剛, 村山貞之ほか (編) : 胸部のCT, 第4版, メディカル・サイエンス・インターナショナル, 2018, pp281-308
 
10) Sadohara J, Fujimoto K, Muller NL, et al : Thymic epithelial tumors. Comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas. Eur J Radiol 60 : 70-79, 2006
 
11) WHO Classification of Tumours Editorial Board (ed) : WHO Classfication of Tumours, Thoracic Tumours (5th ed.), IARC, Lyon, 2021
 
12) 日本肺癌学会 (編) : 肺癌診療ガイドライン 悪性胸膜中皮腫・胸腺腫瘍含む, 2020年版, 金原出版, 2020, pp367-433
 
13) 原眞咲 : 中・後縦隔腫瘍. 村田喜代史, 上甲剛, 村山貞之ほか (編) : 胸部のCT, 第4版, メディカル・サイエンス・インターナショナル, 2018, pp309-335
 
14) 本廣賢子, 長田周治, 藤本公則 : 所見から迫る胸部CT. 後縦隔 (脊椎傍区画) 腫瘤性病変. 日本胸部臨床 75 : 300-311, 2016
 
15) Hattori H : Ciliated cyst of probable mullerian origin arising in the posterior mediastinum. Virchow Arch 446 : 82-84, 2005
 
16) Batt RE, Mhawech-Fauceglia P, Odunsi K, et al : Pathogenesis of mediastinal paravertebral mullerian cysts of Hattori : developmental endosalpingiosis-mullerianosis. Int J Gynecol Pathol 29 : 546-551, 2010
PubMed
17) 佐土原順子, 藤本公則, 末藤伸子ほか : 縦隔腫瘤性病変の画像診断-診断の進め方-. 画像診断 29 : 356-368, 2009
 
18) Carter BW, Marom EM, Detterbeck FC : Approaching the patient with an anterior mediastinal mass : a guide for clinicians. J Thorac Oncol 9 : S102-S109, 2014
 
19) Carter BW, Okumura M, Detterbeck FC, et al : Approaching the patient with an anterior mediastinal mass : a guide for radiologists. J Thorac Oncol 9 : S110-S118, 2014
 
20) Morrissey B, Adams H, Gibbs AR, et al : Percutaneous needle biopsy of the mediastinum : review of 94 procedures. Thorax 48 : 632-637, 1993
PubMed
P.175 掲載の参考文献
1) Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery : Thoracic and cardiovascular surgeries in Japan during 2017 : Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 68 : 414-449, 2020
PubMed
2) Hsu CH, Chan JK, Yin CH, et al : Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States. PLoS One 14 : e0227197, 2019, doi : 10.1371/journal.pone.0227197
 
3) Kondo K, Monden Y : Therapy for thymic epithelial tumors : a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76 : 878-884, 2003
PubMed
4) 近藤和也, 門田康正 : 縦隔腫瘍. 下条文武, 齋藤康 (監) : ダイナミック・メディシン, 第4巻, 西村書店, 2003, pp189-196
 
5) Zhao J, Bhatnagar V, Ding L, et al : A systematic review of paraneoplastic syndromes associated with thymoma : Treatment modalities, recurrence, and outcomes in resected cases. J Thorac Cardiovasc Surg 160 : 306-314, 2020
 
6) Nakajima J, Okumura M, Yano M, et al : Myasthenia gravis with thymic epithelial tumour : a retrospective analysis of a Japanese database. Eur J Cardiothorac Surg 49 : 1510-1515, 2016
PubMed
7) Filosso PL, Guerrera F, Rendina AE, et al : Outcome of surgically resected thymic carcinoma : a multicenter experience. Lung Cancer 83 : 205-210, 2014
PubMed
8) Nakajima J, Murakawa T, Fukami T, et al : Postthymectomy myasthenia gravis : relationship with thymoma and antiacetylcholine receptor antibody. Ann Thorac Surg 86 : 941-945, 2008
PubMed
9) Detterbeck FC : Clinical value of the WHO classification system of thymoma. Ann Thorac Surg 81 : 2328-2334, 2006
PubMed
10) 日本呼吸器外科学会, 呼吸器外科専門医合同委員会 (編) : 呼吸器外科テキスト, 改訂第2版, 南江堂, 2021, pp379-384
 
11) Bergh NP, Gatzinsky P, Larsson S, et al : Tumors of the thymus and thymic region : I. Clinicopathological studies on thymomas. Ann Thorac Surg 25 : 91-98, 1978
PubMed
12) Wilkins EW Jr, Castleman B : Thymoma : a continuing survey at the Massachusetts General Hospital. Ann Thorac Surg 28 : 252-256, 1979
PubMed
13) Masaoka A, Monden Y, Nakahara K, et al : Follow-up study of thymomas with special reference to their clinical stages. Cancer 48 : 2485-2492, 1981
PubMed
14) Detterbeck FC, Parsons AM : Thymic tumors. Ann Thorac Surg 77 : 1860-1869, 2004
PubMed
15) Detterbeck FC, Nicholson AG, Kondo K, et al : The Masaoka-Koga stage classification for thymic malignancies : clarification and definition of terms. J Thorac Oncol 6 : S1710-S1716, 2011
PubMed
16) Detterbeck FC, Stratton K, Giroux D, et al : The IASLC/ITMIG Thymic Epithelial Tumors Staging Project : Proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9 : S65-S72, 2014
PubMed
17) Brierley JD, Gospodarowicz MK, Wittekind C (eds) : TNM Classification of Malignant Tumours (8th ed.), Wiley-Blackwell, Hoboken, 2017
 
18) Nicholson AG, Detterbeck FC, Marino M, et al : The IASLC/ITMIG Thymic Epithelial Tumors Staging Project : proposals for the T component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9 : S73-S80, 2014
 
19) Kondo K, Van Schil P, Detterbeck FC, et al : The IASLC/ITMIG Thymic Epithelial Tumors Staging Project : proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9 : S81-S87, 2014
 
20) Bhora FY, Chen DJ, Detterbeck FC, et al : The ITMIG/IASLC thymic epithelial tumors staging project : a proposed lymph node map for thymic epithelial tumors in the forthcoming 8th edition of the TNM classification of malignant tumors. J Thorac Oncol 9 : S88-S96, 2014
 
21) 日本胸腺研究会 (編) : 臨床・病理 縦隔腫瘍取扱い規約, 第1版, 金原出版, 2009, pp36-44
 
P.183 掲載の参考文献
1) Brierley JD, Gospodarowicz MK, Wittekind C (eds) : TNM Classification of Malignant Tumours (8th ed.), Wiley-Blackwell, Hoboken, 2017
 
2) 日本肺癌学会 : 肺癌診療ガイドライン 悪性胸膜中皮腫・胸腺腫瘍含む, 2021年版. https://www.haigan.gr.jp/guideline/2021/ (2022年3月閲覧)
 
3) Abdel Razek AA, Khairy M, Nada N : Diffusion-weighted MR imaging in thymic epithelial tumors : correlation with World Health Organization classification and clinical staging. Radiology 273 : 268-275, 2014
PubMed
4) Kong LY, Zhang W, Zhou Y, et al : Histogram analysis of apparent diffusion coefficient maps for assessing thymic epithelial tumours : correlation with world health organization classification and clinical staging. Br J Radiol 91 : 20170580, 2018
PubMed
5) Fukumoto K, Taniguchi T, Ishikawa Y, et al : The utility of [18F] -fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours. Eur J Cardiothorac Surg 42 : e152-156, 2012
PubMed
6) Treglia G, Sadeghi R, Giovanella L, et al : Is (18) F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis. Lung Cancer 86 : 5-13, 2014
PubMed
7) Iwashita T, Yasuda I, Doi S, et al : The yield of endoscopic ultrasound-guided fine needle aspiration for histological diagnosis in patients suspected of stage I sarcoidosis. Endoscopy 40 : 400-405, 2008
 
8) Okumura M : System for thymic disease research and clinical practice in Japan. Mediastinum 5 : 7, 2021
PubMed
9) Masaoka A, Yamakawa Y, Niwa H, et al : Extended thymectomy for myasthenia gravis patients : a 20-year review. Ann Thorac Surg 62 : 853-859, 1996
PubMed
10) Chao YK, Liu YH, Hsieh MJ, et al : Long-term outcomes after thoracoscopic resection of stage I and II thymoma : a propensity-matched study. Ann Surg Oncol 22 : 1371-1376, 2015
 
11) Liu TJ, Lin MW, Hsieh MS, et al : Video-assisted thoracoscopic surgical thymectomy to treat early thymoma : a comparison with the conventional transsternal approach. Ann Surg Oncol 21 : 322-328, 2014
PubMed
12) Ye B, Tantai JC, Ge XX, et al : Surgical techniques for early-stage thymoma : video-assisted thoracoscopic thymectomy versus transsternal thymectomy. J Thorac Cardiovasc Surg 147 : 1599-1603, 2014
PubMed
13) Pennathur A, Qureshi I, Schuchert MJ, et al : Comparison of surgical techniques for early-stage thymoma : feasibility of minimally invasive thymectomy and comparison with open resection. J Thorac Cardiovasc Surg 141 : 694-701, 2011
PubMed
14) Yano M, Fujii Y, Yoshida J, et al : A phase II study of partial and subtotal thymectomy for thymoma (JART02). World J Surg 41 : 2033-2038, 2017
 
15) Kondo K, Monden Y : Therapy for thymic epithelial tumors : a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76 : 878-884, 2003
PubMed
16) Omasa M, Date H, Sozu T, et al : Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors : the Japanese Association for Research on the Thymus Database Study. Cancer 121 : 1008-1016, 2015
 
17) Rimner A, Yao X, Huang J, et al : Postoperative radiation therapy is associated with longer overall survival in completely resected stage II and III thymoma-an analysis of the International Thymic Malignancies Interest Group retrospective database. J Thorac Oncol 11 : 1785-1792, 2016
PubMed
18) Shepherd A, Riely G, Detterbeck F, et al : Thymic Carcinoma Management Patterns among International Thymic Malignancy Interest Group (ITMIG) Physicians with Consensus from the Thymic Carcinoma Working Group. J Thorac Oncol 12 : 745-751, 2017
 
19) Hamdi S, Mercier O, Fadel E, et al : Is sacrifying the phrenic nerve during thymoma resection worthwhile? Eur J Cardiothorac Surg 45 : e151-155, 2014
PubMed
20) Yano M, Sasaki H, Moriyama S, et al : Preservation of phrenic nerve involved by stage III thymoma. Ann Thorac Surg 89 : 1612-1619, 2010
PubMed
21) Korst RJ, Bezjak A, Blackmon S, et al : Neoadjuvant chemoradiotherapy for locally advanced thymic tumors : a phaseII, multi-institutional clinical trial. J Thorac Cardiovasc Surg 147 : 36-44, 2014
 
22) Kim ES, Putnam JB, Komaki R, et al : PhaseII study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas : final report. Lung Cancer 44 : 369-379, 2004
 
23) Loehrer PJ Sr, Chen M, Kim K, et al : Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma : an intergroup trial. J Clin Oncol 15 : 3093-3099, 1997
 
24) Friedant AJ, Handorf EA, Su S, et al : Minimally invasive versus open thymectomy for thymic malignancies : systematic review and meta-analysis. J Thorac Oncol 11 : 30-38, 2016
PubMed
25) Huang J, Riely GJ, Rosenzweig KE, et al : Multimodality therapy for locally advanced thymomas : state of the art or investigational therapy? Ann Thorac Surg 85 : 365-367, 2008
PubMed
26) Ishikawa Y, Matsuguma H, Nakahara R, et al : Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity : the potential role of extrapleural pneumonectomy. Ann Thorac Surg 88 : 952-957, 2009
PubMed
27) Kaba E, Ozkan B, Erus S, et al : Role of surgery in the treatment of Masaoka stage IVa thymoma. Ann Thorac Cardiovasc Surg 24 : 6-12, 2018
PubMed
28) Wright CD, Kessler KA : Surgical treatment of thymic tumors. Semin Thorac Cardiovasc Surg 17 : 20-26, 2005
PubMed
29) Huang J, Rizk NP, Travis WD, et al : Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg 134 : 1477-1483, 2007
PubMed
30) Lee HS, Jang HJ, Lo EM, et al : Povidone-iodine results in rapid killing of thymic epithelial tumour cells through cellular fixation†. Interact Cardiovasc Thorac Surg 28 : 353-359, 2019
 
31) Nakajima J, Okumura M, Yano M, et al : Myasthenia gravis with thymic epithelial tumour : a retrospective analysis of a Japanese database. Eur J Cardiothorac Surg 49 : 1510-1515, 2016
PubMed
32) Padda SK, Yao X, Antonicelli A, et al : Paraneoplastic syndromes and thymic malignancies : an examination of the International Thymic Malignancy Interest Group retrospective database. J Thorac Oncol 13 : 436-446, 2018
PubMed
33) Yellin A, Simansky DA, Ben-Avi R, et al : Resection and heated pleural chemoperfusion in patients with thymic epithelial malignant disease and pleural spread : a single-institution experience. J Thorac Cardiovasc Surg 145 : 83-87, 2013
PubMed
34) Maury JM, Girard N, Tabutin M, et al : Intra-thoracic chemo-hyperthermia for pleural recurrence of thymoma. Lung Cancer 108 : 1-6, 2017
PubMed
35) Mukherjee S, Ibrahimi S, John S, et al : Non-seminomatous mediastinal germ cell tumor and acute megakaryoblastic leukemia. Ann Hematol 96 : 1435-1439, 2017
PubMed
36) Yano M, Sasaki H, Moriyama S, et al : Clinicopathological analysis of small-sized anterior mediastinal tumors. Surg Today 44 : 1817-1822, 2014
PubMed
P.188 掲載の参考文献
1) Detterbeck FC, Nicholson AG, Kondo K, et al : The Masaoka-Koga stage classification for thymic malignancies : clarification and definition of terms. J Thorac Oncol 6 (7 Suppl 3) : S1710-1716, 2011
 
2) Detterbeck FC, Stratton K, Giroux D, et al : The IASLC/ITMIG Thymic Epithelial Tumors Staging Project : proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9 (9 Suppl 2) : S65-72, 2014
 
3) Nicholson AG, Detterbeck FC, Marx A, et al : Dataset for reporting of thymic epithelial tumours : recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology 70 : 522-538, 2017
 
4) International Collaboration on Cancer Reporting (ICCR) : http://www.iccr-cancer.org/ (2022年3月閲覧)
 
5) Guillou L, Coindre JM, Bonichon F, et al : Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 15 : 350-362, 1997
 

[ 胸膜腫瘍 ]

P.195 掲載の参考文献
1) 日本肺癌学会 (編) : 臨床・病理 肺癌取扱い規約, 第8版 補訂版, 金原出版, 2021
 
2) 石綿・中皮腫研究会/日本中皮腫研究機構/日本肺癌学会 (編) : 中皮腫瘍取扱い規約, 第1版, 金原出版, 2018
 
3) Nicholson AG, Sauter JL, Nowak AK, et al : EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma : towards a more multidisciplinary approach. J Thorac Oncol 15 : 29-49, 2020
PubMed
4) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours, Thoracic Tumours (5th ed.), IARC, Lyon, 2021
 
5) Whitaker D, Henderson DW, Shilkin KB : The concept of mesothelioma in situ : implications for diagnosis and histogenesis. Semin Diagn Pathol 9 : 151-161, 1992
PubMed
6) Henderson DW, Shilkin KB, Whitaker D : Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ : a brief review. Am J Clin Pathol 110 : 397-404, 1998
 
7) Churg A, Hwang H, Tan L, et al : Malignant mesothelioma in situ. Histopathology 72 : 1033-1038, 2018
PubMed
8) Churg A, Galateau-Salle F, Roden AC, et al : Malignant mesothelioma in situ : morphologic features and clinical outcome. Mod Pathol 33 : 297-302, 2020
PubMed
9) Kadota K, Suzuki K, Colovos C, et al : A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma. Mod Pathol 25 : 260-271, 2012
PubMed
10) Rosen LE, Karrison T, Ananthanarayanan V, et al : Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma : a multi-institutional study. Mod Pathol 31 : 598-606, 2018
PubMed
11) Zhang, YZ, Brambilla C, Molyneaux PL, et al : Utility of nuclear grading system in epithelioid malignant pleural mesothelioma in biopsy-heavy setting : an external validation study of 563 cases. Am J Surg Pathol 44 : 347-356, 2020
PubMed
12) Churg A, Gagle PT, Roggli VL (eds.) : Atlas of Tumor Pathology, Series 4, Tumors of the Serosal Membranes, AFIP, Washington DC, 2006
 
13) Galateau Salle F, Le Stang N, Nicholson AG, et al : New insights on diagnostic reproducibility of biphasic mesotheliomas : a multi-institutional evaluation by the international mesothelioma panel from the MESOPATH Reference Center. J Thorac Oncol 13 : 1189-1203, 2018
 
14) Galateau Salle F, Le Stang N, Tirode F, et al : Comprehensive molecular and pathologic evaluation of transitional mesothelioma assisted by deep learning approach : a multi-institutional study of the international mesothelioma panel from the MESOPATH Reference Center. J Thorac Oncol 15 : 1037-1053, 2020
 
15) Vigneswaran WT, Kircheva DY, Ananthanarayanan V, et al : Amount of epithelioid differentiation is a predictor of survival in malignant pleural mesothelioma. Ann Thorac Surg 103 : 962-966, 2017
PubMed
16) Beasley MB, Galateau-Salle F, Dacic S : Pleural mesothelioma classification update. Virchows Arch 478 : 59-72, 2021
PubMed
17) Wu D, Hiroshima K, Yusa T, et al : Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma. Ann Diagn Pathol 26 : 31-37, 2017
 
18) Righi L, Duregon E, Vatrano S, et al : BRCA1-associated protein 1 (BAP1) immunohistochemical expression as a diagnostic tool in malignant pleural mesothelioma classification : a large retrospective study. J Thorac Oncol 11 : 2006-2017, 2016
PubMed
19) De Rienzo A, Chirieac LR, Hung YP, et al : Large-scale analysis of BAP1 expression reveals novel associations with clinical and molecular features of malignant pleural mesothelioma. J Pathol 253 : 68-79, 2021
PubMed
20) Marchevsky AM, LeStang N, Hiroshima K, et al : The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung : evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center. Hum Pathol 67 : 160-168, 2017
PubMed
21) Berg KB, Churg A : GATA3 immunohistochemistry for distinguishing sarcomatoid and desmoplastic mesothelioma from sarcomatoid carcinoma of the lung. Am J Surg Pathol 41 : 1221-1225, 2017
PubMed
22) Amatya VJ, Kushitani K, Mawas AS, et al : MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Mod Pathol 30 : 672-681, 2017
PubMed
23) Berg KB, Ionescu D, Churg AM : MUC4 staining in sarcomatoid carcinomas. Mod Pathol 32 : 157, 2019
PubMed
24) Terra SBSP, Roden AC, Aubry MC, et al : Utility of immunohistochemistry for MUC4 and GATA3 to aid in the distinction of pleural sarcomatoid mesothelioma from pulmonary sarcomatoid carcinoma. Arch Pathol Lab Med 145 : 208-213, 2021
PubMed
25) Andrici J, Sheen A, Sioson L, et al : Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology. Mod Pathol 28 : 1360-1368, 2015
 
26) Walts AE, Hiroshima K, McGregor SM, et al : BAP1 immunostain and CDKN2A (p16) FISH analysis : clinical applicability for the diagnosis of malignant mesothelioma in effusions. Diagn Cytopathol 44 : 599-606, 2016
 
27) Hida T, Hamasaki M, Matsumoto S, et al : Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis : Comparison with 9p21 FISH and BAP1 immunohistochemistry. Lung Cancer 104 : 98-105, 2017
PubMed
28) Kinoshita Y, Hida T, Hamasaki M, et al : A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma. Cancer Cytopathol 126 : 54-63, 2018
 
29) Kinoshita Y, Hamasaki M, Matsumoto S, et al : Genomicbased ancillary assays offer improved diagnostic yield of effusion cytology with potential challenges in malignant pleural mesothelioma. Pathol Int 70 : 671-679, 2020
 
30) Chapel DB, Schulte JJ, Absenger G, et al : Malignant peritoneal mesothelioma : prognostic significance of clinical and pathologic parameters and validation of a nucleargrading system in a multi-institutional series of 225 cases. Mod Pathol 34 : 380-395, 2021
 
P.205 掲載の参考文献
1) 日本肺癌学会 : 肺癌診療ガイドライン 悪性胸膜中皮腫・胸腺腫瘍含む, 2021年版. https://www.haigan.gr.jp/guideline/2021/ (2022年3月閲覧)
 
2) Scherpereel A, Opitz I, Berghmans T, et al : ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur Respir J 55 : 1900953, 2020
PubMed
3) Boutin C, Rey F : Thoracoscopy in pleural malignant mesothelioma : a prospective study of 188 consecutive patients. Part 1 : Diagnosis. Cancer 72 : 389-393, 1993
PubMed
4) Grossebner MW, Arifi AA, Goddard M, et al : Mesothelioma-VATS biopsy and lung mobilization improves diagnosis and palliation. Eur J Cardiothorac Surg 619-623, 1999
PubMed
5) Attanoos RL, Gibbs AR : The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma. Histopathology 53 : 340-344, 2008
PubMed
6) Marchevsky AM, Husain AN, Galateau-Salle F, et al (eds) : Practical Pathology of Serous Membranes. Cambridge University Press, Cambridge, 2018
 
7) 日本病理学会 (編) : ゲノム研究用・診療用病理組織検体取扱い規程, 羊土社, 2019
 
8) Kinoshita Y, Hida T, Hamasaki M, et al : A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma. Cancer Cytopathol 126 : 54-63, 2018
 
9) 日本臨床細胞学会 : がんゲノム診療における細胞検体の取扱い指針, 第1.0版, 2021. http://jscc.or.jp/guideline/ (2022年3月閲覧)
 
10) Ordonez NG : The immunohistochemical diagnosis of mesothelioma : a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 27 : 1031-1051, 2003
PubMed
11) Exarchos GD, Attanoos RL : Pseudomesotheliomatous small-cell neuroendocrine carcinoma of the lung with calretinin expression. Histopathology 66 : 895-896, 2015
PubMed
12) Attanoos RL, Pugh MR : The diagnosis of pleural tumors other than mesothelioma. Arch Pathol Lab Med 142 : 902-913, 2018
 
P.212 掲載の参考文献
1) Sugarbaker DJ, Mentzer SJ, Strauss G : Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. Ann Thorac Surg 54 : 941-946, 1992
PubMed
2) Rusch VW : Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma. Chest 103 (4 Suppl) 382S-384S, 1993
 
3) 中野孝司 (編) : 胸膜全書 胸膜疾患のグローバルスタンダード, 医薬ジャーナル社, 2013
 
4) Pass H, Giroux D, Kennedy C, et al : The IASLC mesothelioma staging project : improving staging of a rare disease through international participation. J Thorac Oncol 11 : 2082-2088, 2016
PubMed
5) Nowak AK, Chansky K, Rice DC, et al : The IASLC mesothelioma staging project : proposals for revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma. J Thorac Oncol 11 : 2089-2099, 2016
 
6) Rice D, Chansky K, Nowak A, et al : The IASLC mesothelioma staging project : proposals for revisions of the N descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma. J Thorac Oncol 11 : 2100-2111, 2016
 
7) Rusch VW, Chansky K, Kindler HL, et al : The IASLC mesothelioma staging project : proposals for the M descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for mesothelioma. J Thorac Oncol 11 : 2112-2119, 2016
 
8) Flores RM, Pass HI, Seshan VE, et al : Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleral mesothelioma : results in 663 patients. J Thorac Cardiovasc Surg 135 : 620-626, 626 e1-3, 2008
 
9) Hasegawa S : Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma. Gen Thorac Cardiovasc Surg 62 : 516-521, 2014
 
P.216 掲載の参考文献
1) Hiroshima K, Karpathiou G : Adenomatoid tumor of the pleura. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp196-197
 
2) Kaplan MA, Tazelaar HD, Hayashi T, et al : Adenomatoid tumors of the pleura. Am J Surg Pathol 20 : 1219-1223, 1996
PubMed
3) Hes O, Perez-Montiel DM, Cabrero IA, et al : Thread-like bridging strands : a morphologic feature present in all adenomatoid tumors. Ann Diagn Pathol 7 : 273-277, 2003
 
4) Sangoi AR, McKenney JK, Schwartz EJ, et al : Adenomatoid tumors of the female and male genital tracts : a clinicopathological and immunohistochemical study of 44 cases. Mod Pathol 22 : 1228-1235, 2009
PubMed
5) Itami H, Fujii T, Nakai T, et al : TRAF7 mutations and immunohistochemical study of uterine adenomatoid tumor compared with malignant mesothelioma. Hum Pathol 111 : 59-66, 2021
PubMed
6) Erber R, Warth A, Muley T, et al : BAP1 loss is a useful adjunct to distinguish malignant mesothelioma including the adenomatoid-like variant from benign adenomatoid tumors. Appl Immunohistochem Mol Morphol 28 : 67-73, 2020
PubMed
7) Goode B, Joseph NM, Stevers M, et al : Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation. Mod Pathol 31 : 660-673, 2018
PubMed
P.220 掲載の参考文献
1) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours, Thoracic Tumours (5th ed.), IARC, Lyon, 2021, pp198-199
 
2) Butnor KJ, Sporn TA, Hammar SP, et al : Well-differentiated papillary mesothelioma. Am J Surg Pathol 25 : 1304-1309, 2001
PubMed
3) Galateau-Salle F, Vignaud JM, Burke L, et al : Well-differentiated papillary mesothelioma of the pleura : a series of 24 cases. Am J Surg Pathol 28 : 534-540, 2004
PubMed
4) Chen X, Sheng W, Wang J : Well-differentiated papillary mesothelioma : a clinicopathological and immunohistochemical study of 18 cases with additional observation. Histopathology 62 : 805-813, 2013
 
5) Sun M, Zhao L, Weng Lao I, et al : Well-differentiated papillary mesothelioma : A 17-year single institution experience with a series of 75 cases. Ann Diagn Pathol 38 : 43-50, 2019
PubMed
6) Churg A, Allen T, Borczuk AC, et al : Well-differentiated papillary mesothelioma with invasive foci. Am J Surg Pathol 38 : 990-998, 2014
PubMed
7) Chiosea S, Krasinskas A, Cagle PT, et al : Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas. Mod Pathol 21 : 742-747, 2008
PubMed
8) Cigognetti M, Lonardi S, Fisogni S, et al : BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations. Mod Pathol 28 : 1043-1057, 2015
PubMed
9) Hida T, Hamasaki M, Matsumoto S, et al : Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis : Comparison with 9p21 FISH and BAP1 immunohistochemistry. Lung Cancer 104 : 98-105, 2017
PubMed
10) Chapel DB, Schulte JJ, Berg K, et al : MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma. Mod Pathol 33 : 245-254, 2020
PubMed
11) Lee HE, Molina JR, Sukov WR, et al : BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma. Hum Pathol 79 : 168-176, 2018
PubMed
12) Costanzo L, Scarlata S, Perrone G, et al : Malignant transformation of well-differentiated papillary mesothelioma 13 years after the diagnosis : a case report. Clin Respir J 8 : 124-129, 2014
PubMed
13) Ribeiro C, Campelos S, Moura CS, et al : Well-differentiated papillary mesothelioma : clustering in a Portuguese family with a germline BAP1 mutation. Ann Oncol 24 : 2147-2150, 2013
 
14) Stevers M, Rabban JT, Garg K, et al : Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42. Mod Pathol 32 : 88-99, 2019
PubMed
P.223 掲載の参考文献
1) Whitaker D, Henderson DW, Shilkin KB : The concept of mesothelioma in situ : implications for diagnosis and histogenesis. Semin Diagn Pathol 9 : 151-161, 1992
PubMed
2) Henderson DW, Shilkin KB, Whitaker D, et al : Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ : a brief review. Am J Clin Pathol 110 : 397-404, 1998
 
3) Pulford E, Henderson DW, Klebe S : Malignant mesothelioma in situ : diagnostic and clinical considerations. Pathology 52 : 635-642, 2020
PubMed
4) Churg A, Hwang H, Tan L, et al : Malignant mesothelioma in situ. Histopathology 72 : 1033-1038, 2018
PubMed
5) Churg A, Galateau-Salle F, Roden AC, et al : Malignant mesothelioma in situ : morphologic features and clinical outcome. Mod Pathol 33 : 297-302, 2020
PubMed
6) Churg A, Dacic S, Galateau-Salle F, et al : Malignant mesothelioma in situ : clinical and pathologic implications. J Thorac Oncol 15 : 899-901, 2020
PubMed
7) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours, Thoracic Tumours (5th ed.), IARC, Lyon, 2021, pp200-201
 
8) Minami K, Jimbo N, Tanaka Y, et al : Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A : a case report. Virchows Arch 476 : 469-473, 2020
PubMed
9) Hidaka K, Takeda T, Kinoshita Y, et al : Development of mesothelioma in situ and its progression to invasive disease observed in a patient with uncontrolled pleural effusions for 15 years. Pathol Int 70 : 1009-1014, 2020
 
10) Beasley MB, Galateau-Salle F, Dacic S : Pleural mesothelioma classification update. Virchows Arch 478 : 59-72, 2021
PubMed
11) Walts AE, Hiroshima K, McGregor SM, et al : BAP1 immunostain and CDKN2A (p16) FISH analysis : clinical applicability for the diagnosis of malignant mesothelioma in effusions. Diagn Cytopathol 44 : 599-606, 2016
 
12) Kinoshita Y, Hida T, Hamasaki M, et al : A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma. Cancer Cytopathol 126 : 54-63, 2018
 
13) Chevrier M, Monaco SE, Jerome JA, et al : Testing for BAP1 loss and CDKN2A/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology. Cancer Cytopathol 128 : 939-947, 2020
PubMed
14) Hmeljak J, Sanchez-Vega F, Hoadley KA, et al : Integrative molecular characterization of malignant pleural mesothelioma. Cancer Discov 8 : 1548-1565, 2018
PubMed
15) Dacic S, Roy S, Lyons MA, et al : Whole exome sequencing reveals BAP1 somatic abnormalities in mesothelioma in situ. Lung Cancer 149 : 1-4, 2020
PubMed
16) Kukuyan AM, Sementino E, Kadariya Y, et al : Inactivation of Bap1 cooperates with losses of Nf2 and Cdkn2a to drive the development of pleural malignant mesothelioma in conditional mouse models. Cancer Res 79 : 4113-4123, 2019
PubMed
P.234 掲載の参考文献
1) Hasleton PS, Galateau-Salle F, King J, et al : Disease of the pleural, Cambridge University Press, Cambridge, 2013
 
2) 環境再生保全機構 : 医師, 医療機関等の皆様へ「石綿健康被害者の救済へのご協力のお願い～中皮腫・肺がん編」https://www.erca.go.jp/asbestos/general/pdf/doc_haigan.pdf (2022年3月閲覧)
 
3) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours, Thoracic Tumours. IARC, Lyon, 2021, pp204-219
 
4) 石綿・中皮腫研究会・日本中皮腫研究機構・日本肺癌学会 (編) : 中皮腫瘍取扱い規約, 第1版, 金原出版, 2018
 
5) Takeshima Y, Inai K, Amatya VJ, et al : Accuracy of pathological diagnosis of mesothelioma cases in Japan : clinicopathological analysis of 382 cases. Lung Cancer 66 : 191-197, 2009
PubMed
6) Mogi A, Nabeshima K, Hamasaki M, et al : Pleural malignant mesothelioma with invasive micropapillary component and its association with pulmonary metastasis. Pathol Int 59 : 874-879, 2009
PubMed
7) Bueno R, Stawiski EW, Goldstein LD, et al : Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet 48 : 407-416, 2016
PubMed
8) Mavrakis KJ, McDonald ER 3rd, Schlabach MR, et al : Disordered methionine metabolism in MTAP/CDKN2Adeleted cancers leads to dependence on PRMT5. Science 351 : 1208-1213, 2016
PubMed
9) Husain AN, Colby TV, Ordonez NG, et al : Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med 142 : 89-108, 2018
PubMed
10) Takeshima Y, Amatya VJ, Kushitani K, et al : Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Histopathology 54 : 667-676, 2009
PubMed
11) Amatya VJ, Kushitani K, Mawas AS, et al : MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Mod Pathol 30 : 672-681, 2017
PubMed
12) Berg KB, Churg A : GATA3 immunohistochemistry for distinguishing sarcomatoid and desmoplastic mesothelioma from sarcomatoid carcinoma of the lung. Am J Surg Pathol 41 : 1221-1225, 2017
PubMed
13) Klebe S, Mahar A, Henderson DW, et al : Malignant mesothelioma with heterologous elements : clinicopathological correlation of 27 cases and literature review. Mod Pathol 21 : 1084-1094, 2008
PubMed
14) Wu D, Hiroshima K, Matsumoto S, et al : Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis. Am J Clin Pathol 139 : 39-46, 2013
PubMed
15) Barak S, Wang Z, Miettinen M : Immunoreactivity for calretinin and keratins in desmoid fibromatosis and other myofibroblastic tumors : a diagnostic pitfall. Am J Surg Pathol 36 : 1404-1409, 2012
PubMed
16) Miettinen M, Limon J, Niezabitowski A, et al : Calretinin and other mesothelioma markers in synovial sarcoma : analysis of antigenic similarities and differences with malignant mesothelioma. Am J Surg Pathol 25 : 610-617, 2001
PubMed
17) 豊國伸哉 : 石綿の曝露はヒト体内で何を起こすのか 動物実験を用いた研究. 井内康輝 (編著) : 石綿関連疾患の病理とそのリスクコミュニケーション, 篠原出版新社, 2015, pp23-29
 
P.238 掲載の参考文献
1) Allen TC, Cagle PT, Churg AM, et al : Localized malignant mesothelioma. Am J Surg Pathol 29 : 866-873, 2005
PubMed
2) Churg A, Roggli V, Chirieac LR, et al : Tumours of the pleura. Mesothelial tumours. Localized malignant mesothelioma. in Travis WD, Brambilla E, Burke AP, et al (eds) : "WHO Classification of Tumours of The Lung, Pleura, Thymus and Heart" (4 th ed.), IARC, Lyon, 2015, p169
 
3) Okike N, Bernatz PE, Woolner LB : Localized mesothelioma of the pleura : benign and malignant variants. J Thorac Cardiovasc Surg 75 : 363-372, 1978
PubMed
4) Crotty TB, Myers JL, Katzenstein AL, et al : Localized malignant mesothelioma. A clinicopathologic and flow cytometric study. Am J Surg Pathol 18 : 357-363,1994
PubMed
5) Teo A, Hemmings C, Miller R : Sarcomatoid localized mesothelioma mimicking intrapulmonary synovial sarcoma : a case report and review of the literature. Pathology 42 : 182-184, 2010
PubMed
6) Asioli S, Dal Piaz G, Damiani S : Localized pleural malignant mesothelioma. Report of two cases simulating pulmonary carcinoma and review of the literature. Virchows Arch 445 : 206-209, 2004.
 
7) Kawai T, Ogata S, Nakashima H, et al : Clinicopathologic study of deciduoid mesothelioma using SMARCB1/INI1 immunohistochemistry and fluorescence in situ hybridization. Hum Pathol 93 : 23-29, 2019
PubMed
8) Okamura H, Kamei T, Mitsuno A, et al : Localized malignant mesothelioma of the pleura. Pathol Int 51 : 654-660, 2001
PubMed
9) Hida T, Hamasaki M, Matsumoto S, et all Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis : Comparison with 9p21 FISH and BAP1 immunohistochemistry. Lung Cancer 104 : 98-105, 2017
 
10) Hung YP, Dong F, Dubuc AM, et al : Molecular characterization of localized pleural mesothelioma. Mod Pathol 33 : 271-280, 2020
PubMed
P.242 掲載の参考文献
1) Jones D, Ballestas ME, Kaye KM, et al : Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. N Engl J Med 339 : 444-449, 1998
 
2) Swerdlow SH, Campo E, Pileri SA, et al : The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127 : 2375-2390, 2016
PubMed
3) Campogiani L, Cerva C, Maffongelli G, et al : Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir. AIDS Res Ther 16 : 15, 2019
 
4) Hu Z, Pan Z, Chen W, et al : Primary Effusion Lymphoma : A Clinicopathological Study of 70 Cases. Cancers (Basel) 13 : 878, 2021
PubMed
5) Kalogeraki A, Haniotis V, Karvelas-Kalogerakis M, et al : Primary effusion lymphoma with aberrant T-cell phenotype in an iatrogenically immunosuppressed renal transplant male : cytologic diagnosis in peritoneal fluid. Diagn Cytopathol 43 : 144-148, 2015
 
6) Wang HY, Wang L : Diagnostic pitfall : primary effusion lymphoma with rare cytokeratin immunoreactivity. Blood 127 : 3102, 2016
PubMed
7) An J, Lichtenstein AK, Brent G, et al : The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression : role of the KSHV latency-associated nuclear antigen and the AP1 response element. Blood 99 : 649-654, 2002
PubMed
8) Cesarman E, Mesri EA, Gershengorn MC : Viral G protein-coupled receptor and Kaposi's sarcoma : a model of paracrine neoplasia? J Exp Med 191 : 417-422, 2000
 
9) Awazawa R, Utsumi D, Katano H, et al : High prevalence of distinct human herpesvirus 8 contributes to the high incidence of non-acquired immune deficiency syndrome-associated Kaposi's sarcoma in isolated Japanese islands. J Infect Dis 216 : 850-858, 2017
 
10) Rossi G, Cozzi I, Della Starza I, et al : Human herpesvirus-8-positive primary effusion lymphoma in HIV-negative patients : Single institution case series with a multidisciplinary characterization. Cancer Cytopathol 129 : 62-74, 2021
PubMed
11) Kaji D, Ota Y, Sato Y, et al : Primary human herpesvirus 8-negative effusion-based lymphoma : a large B-cell lymphoma with favorable prognosis. Blood Adv 4 : 4442-4450, 2020
 
12) Wang X, Zou Z, Deng Z, et al : Male hormones activate EphA2 to facilitate Kaposi's sarcoma-associated herpesvirus infection : Implications for gender disparity in Kaposi's sarcoma. PLoS Pathog 13 : e1006580, 2017
 
13) El-Fattah MA : Clinical characteristics and survival outcome of primary effusion lymphoma : A review of 105 patients. Hematol Oncol 35 : 878-883, 2017
PubMed
P.247 掲載の参考文献
1) Iuchi K, Ichimiya A, Akashi A, et al : Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer 60 : 1771-1775, 1987
PubMed
2) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours, Thoracic Tumours (5th ed.), IARC, Lyon, 2021
 
3) Aozasa K, Ohsawa M, Iuchi K, et al : Prognostic factors for pleural lymphoma patients. Jpn J Clin Oncol 21 : 417-421, 1991
PubMed
4) Nakatsuka S, Yao M, Hoshida Y, et al : Pyothorax-associated lymphoma : a review of 106 cases. J Clin Oncol 20 : 4255-4260, 2002
 
5) Narimatsu H, Ota Y, Kami M, et al : Clinicopathological features of pyothorax-associated lymphoma ; a retrospective survey involving 98 patients. Ann Oncol 18 : 122-128, 2007
PubMed
6) 黒崎敦子 : 胸膜, 胸壁のリンパ腫. 日本胸部臨床 70 : 560-569, 2011
Medical*Online
7) 梶大介, 太田泰徳 : 膿胸関連リンパ腫. 深山正久, 野口雅之, 松野吉宏 (編) : 腫瘍病理鑑別診断アトラス 縦隔腫瘍・胸膜腫瘍, 第1版, 文光堂, 2014, pp225-229
 
8) Hongyo T, Kurooka M, Taniguchi E, et al : Frequent p53 mutations at dipyrimidine sites in patients with pyothoraxassociated lymphoma. Cancer Res 58 : 1105-1107, 1998
PubMed
9) Yamato H, Ohshima K, Suzumiya J, et al : Evidence for local immunosuppression and demonstration of c-myc amplification in pyothorax-associated lymphoma. Histopathology 39 : 163-171, 2001
PubMed
10) Ando M, Sato Y, Takata K, et al : A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas. PLoS One 8 : e56741, 2013
PubMed
11) Nishiu M, Yasuhiko T, Nakatsuka S, et al : Distinct pattern of gene expression in pyothorax-associated lymphoma (PAL), a lymphoma developing in long-standing inflammation. Cancer Sci 95 : 828-834, 2004
 
12) Higuchi T, Matsuo K, Hashida Y, et al : Epstein-Barr virus-positive pyothorax-associated lymphoma expresses CCL17 and CCL22 chemokines that attract CCR4-expressing regulatory T cells. Cancer Lett 453 : 184-192, 2019
PubMed
13) Das DK : Serous effusions in malignant lymphomas : a review. Diagn Cytopathol 34 : 335-347, 2006
PubMed
P.251 掲載の参考文献
1) WHO Classification of Tumours Editorial Board (ed) : WHO Classification of Tumours, Thoracic Tumours (5th ed.), IARC, Lyon, 2021, pp459-462
 
2) Cagle PT, Allen TC : Pathology of the pleura : what the pulmonologists need to know. Respirology 16 : 430-438, 2011
PubMed
3) Kushitani K, Amatya VJ, Okada Y, et al : Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma. Histopathology 70 : 375-384, 2017
PubMed
4) Tsuji S, Washimi K, Kageyama T, et al : HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma. Sci Rep 7 : 45768, 2017
PubMed
5) 谷田部恭, 安藤正志 : 原発不明がんにおける病理診断の基本的考え方. 病理と臨床 35 : 129-136, 2017
Medical*Online
6) 森永正二郎 : 原発不明がんの免疫染色. 病理と臨床 35 : 137-151, 2017
Medical*Online
7) 吉田朗彦 : 原発不明癌の診断. 病理と臨床 38 (臨増) : 397-404, 2020
 
8) 比島恒和 : 胸腺. 病理と臨床 38 (臨増) : 136-141, 2020
 
9) Bishop JA, Ogawa T, Chang X, et al : HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. Am J Surg Pathol 36 : 142-148, 2012
PubMed
10) Bahrami A, Truong LD, Ro JY : Undifferentiated tumor : true identity by immunohistochemistry. Arch Pathol Lab Med 132 : 326-348, 2008
PubMed
11) Marchevsky AM, LeStang N, Hiroshima K, et al : The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung : evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center. Hum Pathol 67 : 160-168, 2017
PubMed
P.263 掲載の参考文献
1) Okby NT, Travis WD : Liposarcoma of the pleural cavity : clinical and pathologic features of 4 cases with a review of the literature. Arch Pathol Lab Med 124 : 699-703, 2000
PubMed
2) Wilson RW, Gallateau-Salle F, Moran CA : Desmoid tumors of the pleura : a clinicopathologic mimic of localized fibrous tumor. Mod Pathol 12 : 9-14, 1999
PubMed
3) Takeshima Y, Nakayori F, Nakano T, et al : Extra-abdominal desmoid tumor presenting as an intrathoracic tumor : case report and literature review. Pathol Int 51 : 824-828, 2001
PubMed
4) Mehrad M, LaFramboise WA, Lyons MA, et al : Wholeexome sequencing identifies unique mutations and copy number losses in calcifying fibrous tumor of the pleura : report of 3 cases and review of the literature. Hum Pathol 78 : 36-43, 2018
 
5) Mian I, Abdullaev Z, Morrow B, et al : Anaplastic lymphoma kinase gene rearrangement in children and young adults with mesothelioma. J Thorac Oncol 15 : 457-461, 2020
 
6) Crotty EJ, McAdams HP, Erasmus JJ, et al : Epithelioid hemangioendothelioma of the pleura : clinical and radiologic features. AJR Am J Roentgenol 175 : 1545-1549, 2000
PubMed
7) Anderson T, Zhang L, Hameed M, et al : Thoracic epithelioid malignant vascular tumors : a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions. Am J Surg Pathol 39 : 132-139, 2015
PubMed
8) Shibuya R, Matsuyama A, Shiba E, et al : CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma. Histopathology 67 : 827-835, 2015
PubMed
9) Sharain RF, Gown AM, Greipp PT, et al : Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms : a comparative, 2-laboratory study. Hum Pathol 87 : 65-74, 2019
 
10) Baranov E, McBride MJ, Bellizzi AM, et al : A novel SS18-SSX fusion-specific antibody for the diagnosis of synovial sarcoma. Am J Surg Pathol 44 : 922-933, 2020
 
11) Parkash V, Gerald WL, Parma A, et al : Desmoplastic small round cell tumor of the pleura. Am J Surg Pathol 19 : 659-665, 1995
 
12) Fois AG, Pirina P, Arcadu A, et al : Desmoplastic small round cell tumors of the pleura : a review of the clinical literature. Multidiscip Respir Med 12 : 22, 2017
PubMed
13) Rekhtman N, Montecalvo J, Chang JC, et al : SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas. J Thorac Oncol 15 : 231-247, 2020
PubMed
14) Klebe S, Mahar A, Henderson DW, et al : Malignant mesothelioma with heterologous elements : clinicopathological correlation of 27 cases and literature review. Mod Pathol 21 : 1084-1094, 2008
PubMed
P.270 掲載の参考文献
1) Wick MR, Allen TC, Ritter JH, et al : Pseudoneoplastic Lesions of the Lungs and Pleural Surfaces. in Leslie Ko, Wick MR (eds) : "Practical Pulmonary Pathology : A Diagnostic Approach" (3 rd ed.), Elsevier, Philadelphia, 2018, pp643-663
 
2) 三浦溥太郎, 審良正則 : 胸膜プラーク-臨床. 森永謙二 (編) : 石綿ばく露と石綿関連疾患 基礎知識と補償・救済, 増補新装版, 三信図書, 2008, pp55-61
 
3) Churg A, Cagle PT, Roggli VL (eds) : Atlas of Tumor Pathology, Series 4, Tumor of the Serosal Membrane, AFIP, Washington DC, 2006, pp135-144
 
4) 河原邦光 : 胸膜の非腫瘍性疾患. 病理と臨床 37 : 1062-1072, 2019
Medical*Online
5) 高橋和久 : びまん性胸膜肥厚. 中野孝司 (編) : 胸膜全書胸膜疾患のグローバルスタンダード, 医薬ジャーナル社, 2013, pp200-206
 
6) 三浦溥太郎, 審良正則 : びまん性胸膜肥厚-臨床. 森永謙二 (編) : 石綿ばく露と石綿関連疾患 基礎知識と補償・救済, 増補新装版, 三信図書, 2008, pp189-196
 
7) Hasleton P, Galateau-Salle F, King J, et al : Disease of the pleura. in Hasleton P, Flieder DB (eds) : "Spencer's Pathology of the Lung" (6 th ed.), Cambridge University Press, Cambridge, 2013, pp1444-1448
 
8) Stone JH, Zen Y, Deshpande V : IgG4-related disease. N Engl J Med 366 : 539-551, 2012
PubMed
9) Zen Y, Inoue D, Kitao A, et al : IgG4-related lung and pleural disease : a clinicopathologic study of 21 cases. Am J Surg Pathol 33 : 1886-1893, 2009
PubMed
10) Yasokawa N, Shirai R, Tanaka H, et al : Thoracoscopic Findings in IgG4-related Pleuritis. Intern Med 59 : 257-260, 2020
PubMed
11) Ishida M, Hodohara K, Furuya A, et al : Concomitant occurrence of IgG4-related pleuritis and periaortitis : a case report with review of the literature Int J Clin Exp Pathol 7 : 808-814, 2014
PubMed
12) Choi IH, Jang SH, Lee S, et al : A case report of IgG4-related disease clinically mimicking pleural mesothelioma. Tuberc Respir Dis (Seoul) 76 : 42-45, 2014
 
13) Travis WD, Colby TV, Koss MN, et al : Atlas of Nontumor Pathology, Fascicle 2, Non-Neoplastic Disorders of the Lower Respiratory Tract, AFIP, Washington DC, 2002, pp793-856
 
14) 岸本卓巳 : 円形無気肺. 森永謙二 (編) : 石綿ばく露と石綿関連疾患 基礎知識と補償・救済, 増補新装版, 三信図書, 2008, pp203-208
 
15) Corrin B, Nicholson AG : Pathology of the Lungs (3rd ed.), Churchill Livingstone/Elsevier, London, 2011, pp707-752
 
16) Chan JK, Loo KT, Yau BK, et al : Nodular histiocytic/mesothelial hyperplasia : a lesion potentially mistaken for a neoplasm in transbronchial biopsy. Am J Surg Pathol 21 : 658-663, 1997
PubMed
17) Chikkamuniyappa S, Herrick J, Jagirdar JS : Nodular histiocytic/mesothelial hyperplasia : a potential pitfall. Ann Diagn Pathol 8 : 115-120, 2004
PubMed
18) Bontemps F, Tillie-Leblond I, Coppin MC, et al : Pleural amyloidosis : thoracoscopic aspects. Eur Respir J 8 : 1025-1027, 1995
PubMed
19) Adams AL, Castro, CY, Singh SP, et al : Pleural amyloidosis mimicking mesothelioma : a clinicopathologic study of two cases. Ann Diagn Pathol 5 : 229-232, 2001
PubMed
20) Goldblum JR, Lamps LW, McKenney JK, et al : Rosai and Ackerman's Surgical Pathology (11th ed.), Elsevier, Philadelphia, 2018, pp444-456
 
21) Ghigna MR, Mercier O, Mussot S, et al : Thoracic endometriosis : clinicopathologic updates and issues about 18 cases from a tertiary referring center. Ann Diagn Pathol 19 : 320-325, 2015
 
22) Hwang SM, Lee CW, Lee BS, et al : Clinical features of thoracic endometriosis : A single center analysis. Obstet Gynecol Sci 58 : 223-231, 2015
PubMed
23) Channabasavaiah, AD, Joseph JV : Thoracic endometriosis : revisiting the association between clinical presentation and thoracic pathology based on thoracoscopic findings in 110 patients. Medicine (Baltimore) 89 : 183-188, 2010
PubMed
24) 本田芳宏 : 胸腔内子宮内膜症,月経随伴性気胸. 中野孝司 (編) : 胸膜全書 胸膜疾患のグローバルスタンダード, 医薬ジャーナル社, 2013, pp175-180
 
25) Goldblum JR, Folpe AL, Weiss SW : Enzinger & Weiss's Soft Tissue Tumors (7th ed.), Elsevier, Philadelphia, 2020, pp817-836
 
26) Travis WD, Nicholson AG, Geisinger KR, et al : Atlas of Tumor Pathology, Series 4, Tumors of the Lower Respiratory Tract, AFIP, Washington DC, 2019, pp476-477
 
27) Travis WD, Nicholson AG, Geisinger KR, et al : Atlas of Tumor Pathology, Series 4, Tumors of the Lower Respiratory Tract, AFIP, Washington DC, 2019, pp592-593
 
28) Ozkaya N, Rosenblum MK, Durham BH, et al : The histopathology of Erdheim-Chester disease : a comprehensive review of a molecularly characterized cohort. Mod Pathol 31 : 581-597, 2018
PubMed
P.282 掲載の参考文献
1) Churg A : Neoplastic asbestos-induced disease. in Churg A, Green FHY (eds) : "Pathology of Occupational Lung Disease (2nd ed.)". Williams & Wilkins, Philadelphia, 1998, pp339-391
 
2) Wagner JC, Sleggs CA, Marchand P : Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 17 : 260-271, 1960
PubMed
3) Battifora H, McCaughey WTE : Reactive processes in the serosal membranes. in "Atlas of Tumor Pathology, Series 3, Tumors of the Serosal Membranes". AFIP, Washington DC, 1995, pp9-14
 
4) Churg A, Cagle PT, Roggli VL : Separation of benign and malignant mesothelial proliferations. in"Atlas of Tumor Pathology, Series 4, Tumors of the Serosal Membranes", AFIP, Washington DC, 2006, pp83-101
 
5) Husain AN, Colby TV, Ordonez NG, et al : Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 142 : 89-108, 2018
PubMed
6) Sauter JL, Bueno R, Dacic S, et al : Diffuse pleural mesothelioma. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp204-219
 
7) 辻村亨, 鍋島一樹 : 早期中皮腫と中皮腫の新たな診断ツールとしての遺伝子異常. 病理と臨床 37 : 1082-1088, 2019
Medical*Online
8) Hida T, Hamasaki M, Matsumoto S, et al : BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis : ROC analysis of the two tests. Pathol Int 66 : 563-570, 2016
PubMed
9) Churg A, Naso JR : The separation of benign and malignant mesothelial proliferations : New markers and how to use them. Am J Surg Pathol 44 : e100-e112, 2020
PubMed
10) Kinoshita Y, Hamasaki M, Yoshimura M, et al : Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma. Mod Pathol 33 : 235-244, 2020
 
11) Hida T, Hamasaki M, Matsumoto S, et al : Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis : Comparison with 9p21 FISH and BAP1 immunohistochemistry. Lung Cancer 104 : 98-105, 2017
PubMed
12) Hamasaki M, Kinoshita Y, Yoshimura M, et al : Cytoplasmic MTAP expression loss detected by immunohistochemistry correlates with 9p21 homozygous deletion detected by FISH in pleural effusion cytology of mesothelioma. Histopathology 75 : 153-155, 2019
PubMed
13) Chapel DB, Schulte JJ, Berg K, et al : MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma. Mod Pathol 33 : 245-254, 2020
PubMed
14) 鍋島一樹, 濱崎慎, Prakasit Sa-Ngiamwibool ほか : 線異形成性中皮腫診断におけるMTAP IHCの有用性に関する検討 : 日本国内多施設共同研究 第1報. 令和2年度石綿関連疾患に係る医学的所見の解析調査業務 (中皮腫の遺伝子異常に基づく診断法の開発に関する調査編・第2報) 報告書. 福岡大学, 2021, pp5-13
 
15) Kinoshita Y, Hida T, Hamasaki M, et al : A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma. Cancer Cytopathol 126 : 54-63, 2018
 
P.291 掲載の参考文献
1) Koss MN, Fleming M, Przygodzki RM, et al : Adenocarcinoma simulating mesothelioma : a clinicopathologic and immunohistochemical study of 29 cases. Ann Diagn Pathol 2 : 93-102, 1998
PubMed
2) Attanoos RL, Gibbs AR : 'Pseudomesotheliomatous' carcinomas of the pleura : a 10-year analysis of cases from the environmental lung disease research group, Cardiff. Histopathology 43 : 444-452, 2003
 
3) Ordonez, NG : The immunohistochemical diagnosis of mesothelioma : a Comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 27 : 1031-1051, 2003
PubMed
4) Husain AN, Colby TV, Ordonez NG, et al : Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 142 : 89-108, 2018
PubMed
5) Miettinen M, Sarlomo-Rikala M : Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types : an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura. Am J Surg Pathol 27 : 150-158, 2003
PubMed
6) Hammar SP : Macroscopic, histologic, histochemical, immunohistochemical, and ultrastructural features of mesothelioma. Ultrastruct Pathol 30 : 3-17, 2006
PubMed
7) Mawas AS, Amatya VJ, Kushitani K, et al : MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung. Sci Rep 8 : 134, 2018
PubMed
8) Naso JR, Tsuji S, Churg A : HEG1 is a highly specific and sensitive marker of epithelioid malignant mesothelioma. Am J Surg Pathol 44 : 1143-1148, 2020
PubMed
9) Hiroshima K, Wu D, Koh E, et al : Membranous HEG1 expression is a useful marker in the differential diagnosis of epithelioid and biphasic malignant mesothelioma versus carcinomas. Pathol Int 71 : 604-613, 2021
PubMed
10) Kambara T, Amatya VJ, Kushitani K, et al : SOX6 is a novel immunohistochemical marker for differential diagnosis of epithelioid mesothelioma from lung adenocarcinoma. Am J Surg Pathol 44 : 1259-1265, 2020
PubMed
11) Kai Y, Amatya VJ, Kushitani K, et al : Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma. Histopathology 74 : 545-554, 2019
PubMed
12) Kushitani K, Amatya VJ, Okada Y, et al : Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma. Histopathology 70 : 375-384, 2017
PubMed
13) Ordonez NG : The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung : a comparative study. Mod Pathol 19 : 417-428, 2006
 
14) Amatya VJ, Kushitani K, Mawas AS, et al : MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Mod Pathol 30 : 672-681, 2017
PubMed
15) Terra SBSP, Roden AC, Aubry MC, et al : Utility of immunohistochemistry for MUC4 and GATA3 to aid in the distinction of pleural sarcomatoid mesothelioma from pulmonary sarcomatoid carcinoma. Arch Pathol Lab Med 145 : 208-213, 2021
PubMed
16) Berg KB, Churg A : GATA3 immunohistochemistry for distinguishing sarcomatoid and desmoplastic mesothelioma from sarcomatoid carcinoma of the lung. Am J Surg Pathol 41 : 1221-1225, 2017
PubMed
17) Mayall FG, Gibbs AR : The histology and immunohistochemistry of small cell mesothelioma. Histopathology 20 : 47-51, 1992
PubMed
18) Cavazza A, Rossi G, Agostini L, et al : Small-cell mesothelioma of the pleura : description of a case. Pathologica 94 : 247-252, 2002
PubMed
19) Ordonez NG : Mesotheliomas with small cell features : report of eight cases. Mod Pathol 25 : 689-698, 2012
PubMed
P.297 掲載の参考文献
1) 石綿曝露労働者に発生した疾病の認定基準に関する検討会 : 中皮腫と職業性曝露に関する検討. 石綿曝露労働者に発生した疾病の認定基準に関する検討会報告書, pp14-26, 2003
 
2) Takagi K, Tsuchiya R, Watanabe Y, et al : Surgical approach to pleural diffuse mesothelioma in Japan. Lung Cancer 31 : 57-65, 2001
PubMed
3) Marom EM, Erasmus J, Pass HI, et al : The role of imaging in malignant pleural mesothelioma. Semin Oncol 29 : 26-35, 2002
PubMed
4) Kato K, Gemba K, Fujimoto N, et al : Fatal pleural mesothelioma in Japan (2003-2008) : evaluation of computed tomography findings. Jpn J Radiol 432-438, 2016
PubMed
5) Alexander E, Clark RA, Colley DP, et al : CT of malignant pleural mesothelioma. Am J Roentgenol 137 : 287-291, 1981
 
6) Metintas M, Ucgun I, Elbek O, et al : Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol 41 : 1-9, 2002
PubMed
7) Attanoos RL, Gibbs AR : 'Pseudomesotheliomatous' carcinomas of the pleura : a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff. Histopathology 43 : 444-452, 2003
 
P.305 掲載の参考文献
1) 厚生労働省 : 都道府県 (特別区－指定都市再掲) 別にみた中皮腫による死亡数の年次推移 (平成7年～令和2年) ～人口動態統計 (確定数) より. https://www.mhlw.go.jp/toukei/saikin/hw/jinkou/tokusyu/chuuhisyu20/index.html (2022年3月閲覧)
 
2) Baas P, Scherpereel A, Nowak AK, et al : First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743) : a multicentre, randomised, open-label, phase 3 trial. Lancet 397 : 375-386, 2021
PubMed
3) Siddiqui MT, Schmitt F, Churg A : Proceedings of the American Society of Cytopathology companion session at the 2019 United States and Canadian Academy of Pathology Annual meeting, part 2 : effusion cytology with focus on theranostics and diagnosis of malignant mesothelioma. J Am Soc Cytopathol 8 : 352-361, 2019
PubMed
4) Muruganandan S, Alfonso H, Franklin P, et al : Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma. Br J Cancer 116 : 703-708, 2017
PubMed
5) 亀井敏昭, 岡村宏, 渋田秀美ほか : 悪性中皮腫の体腔液細胞診-中皮腫細胞の特徴と反応性中皮や腺癌との鑑別を主に-. 病理と臨床 22 : 693-700, 2004
Medical*Online
6) Tsao AS, Wistuba I, Roth JA, et al : Malignant pleural mesothelioma. J Clin Oncol 27 : 2081-2090, 2009
PubMed
7) 濱川真治, 森一磨, 柏崎好美ほか : 悪性中皮腫症例の体腔液に出現したhump様細胞質突起を有する鋳型細胞の検討. 日本臨床細胞学会雑誌 42 : 10-16, 2003
 
8) 佐久間暢夫, 亀井敏昭, 渋田秀美ほか : 核数に注目した反応性中皮, 肺腺癌および悪性中皮腫の特徴. 日本臨床細胞学会雑誌 41 : 145-149, 2002
 
9) Sakuma N, Kamei T, Ishihara T : Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant effusions as compared with reactive mesothelial cells. Acta Cytol 43 : 777-785, 1999
PubMed
10) 佐久間暢夫, 岡村宏, 亀井敏昭ほか : 体腔液中に認められるオレンジG 好性細胞の検討. 日本臨床細胞学会雑誌 47 : 351-354, 2008
 
11) 清水勇輝, 上田順子, 亀井敏昭ほか : 悪性中皮腫例の体腔液に出現するorangeophilic cellの電子顕微鏡的検討. 日本臨床細胞学会雑誌 48 : 353-360, 2009
 
12) 畠榮, 鐵原拓雄, 三宅康之ほか : 体腔液細胞診におけるCollagenous stroma を有する細胞集塊の細胞学的特徴ならびに診断的意義について. 日本臨床細胞学会雑誌 35 : 217-223, 1996
 
13) Hasteh F, Lin GY, Weidner N, et al : The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol 118 : 90-96, 2010
PubMed
14) Husain AN, Colby TV, Ordonez NG, et al : Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 142 : 89-108, 2018
PubMed
15) Kinoshita Y, Hida T, Hamasaki M, et al : A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma. Cancer Cytopathol 126 : 54-63, 2018
 
16) Kinoshita Y, Hamasaki M, Matsumoto S, et al : Genomic-based ancillary assays offer improved diagnostic yield of effusion cytology with potential challenges in malignant pleural mesothelioma. Pathol Int 70 : 671-679, 2020
PubMed
P.310 掲載の参考文献
1) Cao C, Tian D, Park J, et al : A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer 83 : 240-245, 2014
 
2) 日本肺癌学会 : 第2部 悪性胸膜中皮腫診療ガイドライン. 肺癌診療ガイドライン 悪性胸膜中皮腫・胸腺腫瘍含む, 2021年版. https://www.haigan.gr.jp/guideline/2021/ (2022年3月閲覧)
 
3) Vogelzang NJ, Rusthoven JJ, Symanowski J, et al : Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol : official journal of the American Society of Clinical Oncology 21 : 2636-2644, 2003
 
4) Zucali PA, Ceresoli GL, Garassino I, et al : Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma. Cancer 112 : 1555-1561, 2008
PubMed
5) Okada M, Kijima T, Aoe K, et al : Clinical Efficacy and Safety of Nivolumab : Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT). Clinical cancer research : an official journal of the American Association for Cancer Research 25 : 5485-5492, 2019
PubMed
6) Baas P, Scherpereel A, Nowak AK, et al : First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743) : a multicentre, randomised, open-label, phase 3 trial. Lancet 397 : 375-386, 2021
PubMed
7) Meyerhoff RR, Yang CF, Speicher PJ, et al : Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database. J Surgi Res 196 : 23-32, 2015
 
8) Vigneswaran WT, Kircheva DY, Ananthanarayanan V, et al : Amount of Epithelioid Differentiation Is a Predictor of Survival in Malignant Pleural Mesothelioma. Ann Thorac Surg 103 : 962-966, 2017
PubMed
P.314 掲載の参考文献
1) Sauter JL, Bueno R, Dacic S, et al : Diffuse pleural mesothelioma. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp204-219
 
2) 鍋島一樹, 濱崎慎 : 胸膜中皮腫におけるupdate. 病理と臨床 39 : 679-686, 2021
Medical*Online
3) 日本肺癌学会 : 肺癌診療ガイドライン 悪性胸膜中皮腫・胸腺腫瘍含む, 2021年版. https://www.haigan.gr.jp/guideline/2021/ (2022年3月閲覧)
 
4) Nicholson AG, Sauter JL, Nowak AK, et al : EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma : towards a more multidisciplinary approach. J Thorac Oncol 15 : 29-49, 2020
PubMed
5) 石綿・中皮腫研究会, 日本中皮腫研究機構, 日本肺癌学会 (編) : 中皮腫瘍取扱い規約, 第1版, 金原出版, 2018
 
6) Attanoos RL, Gibbs AR : The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma. Histopathology 53 : 340-344, 2008
PubMed
P.317 掲載の参考文献
1) Sauter JL, Bueno R, Dacic S, et al : Diffuse pleural mesothelioma. in WHO Classification of Tumours Editorial Board (ed) : "WHO Classification of Tumours, Thoracic Tumours" (5 th ed.), IARC, Lyon, 2021, pp204-219
 
2) 石綿・中皮腫研究会, 日本中皮腫研究機構, 日本肺癌学会 (編) : 中皮腫瘍取扱い規約, 第1版, 金原出版, 2018
 
3) Association of Directors of Anatomic and Surgical Pathology : Recommendations for the reporting of pleural mesothelioma. Am J Clin Pathol Jan 127 : 15-19, 2007
PubMed
4) Brierley JD, Gospodarowicz MK, Wittekind C (eds) : TNM Classification of Malignant Tumours (8th ed.), Wiley-Blackwell, Hoboken, 2016
 
5) 日本癌治療学会, 日本病理学会 (編) : 領域横断的がん取扱い規約, 第1版, 金原出版, 2019
 
6) 日本肺癌学会 (編) : 臨床・病理 肺癌取扱い規約, 第8版 補訂版, 金原出版, 2021
 

書評

最近チェックした商品履歴

Loading...